Stardust Intelligence
China's rope-driven humanoid robot maker targeting retail, industrial, and education sectors
Stardust Intelligence has achieved genuine early commercial traction with its cable-driven humanoid but must prove manufacturing scale, unit economics, and the durability of its unconventional actuator approach before its aggressive valuation is justified.
Cover facts
Company profile
Stardust Intelligence (Astribot, 星尘智能) is a Shenzhen-based humanoid robotics startup founded in December 2022 by ex-Tencent Robotics X engineer Lai Jie, known for its rope/cable-driven (tendon-driven) actuator technology that it claims enables lighter and safer humanoid robots. The company reached unicorn status (>RMB10 billion valuation, ~$1.38B) in mid-2026 through three consecutive Series B rounds raising over RMB1 billion, advised by China Renaissance and backed by Thundersoft, Kede Education, the Liangxi fund, and others. Its T1 humanoid, priced from RMB89,900, launched in May 2026 following the S1 research platform, with thousand-unit orders reported across industrial, retail, and education customers and deployments spanning roughly six Chinese cities.
- Website
- www.astribot.com
- Founded
- 2022-12-01
- Founders
- Lai Jie (赖杰), Dai Yuan (戴媛)
- Founding location
- Shenzhen, China
- Headquarters
- Shenzhen (Nanshan district), China
- Product
- S1 dual-arm research platform (2024) and T1 full-body humanoid (RMB89,900, launched May 2026), built on a Design-for-AI stack combining a Lumo-style AI model, DuoCore-style OS, and a rope/cable-driven body; deployed in industrial, retail, and education settings.
- Customers
- B2B enterprise customers across industrial/logistics, retail, and education sectors; deployments across roughly six Chinese cities.
- Business model
- Hardware sales to enterprise and institutional buyers, with partner/distribution channels; targeting mass-manufacturing scale at its Wuxi facility.
- Stage
- Series B
- Funding status
- >RMB1B raised across three consecutive Series B rounds (B/B+/B++) in mid-2026; unicorn status achieved at >RMB10B (~$1.38B); ~$150M lifetime capital raised.
Executive summary
Top strengths
- First-to-market with a commercially priced humanoid (T1, RMB89,900) built on differentiated rope/cable-driven actuation
- Thousand-unit-scale purchase orders (notably SEER) signal real early demand across industrial, retail, and education
- Strategic backing from Thundersoft plus China Renaissance advisory lends manufacturing, OS, and deal-structuring credibility
- Deployments across roughly six Chinese cities provide early real-world validation within a policy-supported domestic market
Top risks
- Revenue, margins, and unit economics are undisclosed, so the ~$1.38B valuation rests on optionality rather than fundamentals
- Rope/cable-driven actuation is unconventional; long-term reliability, cable wear, and maintenance at scale are unproven
- Intensely competitive China humanoid landscape dominated by the Unitree-AgiBot duopoly plus well-funded global peers
- Rising regulatory and geopolitical exposure, including China HEIS 2026 standards and US legislative moves to restrict Chinese robots
Open gaps
- Audited revenue, margins, and unit economics are undisclosed
- Actuator reliability (MTBF) and manufacturing yield at scale are not independently verified
- Delivered units versus headline order counts, and named end-customers, are not disclosed
- Technical-team credentials and leadership bench depth beyond the founder are thinly documented
Contents
01Company Overview
1.1 Identity, Product, and Business Model
Stardust Intelligence, operating under the Astribot brand (Chinese name 星尘智能, Xingchen Zhineng), is a Shenzhen-based humanoid-robotics company founded in December 2022 by Lai Jie, the first engineer at Tencent Robotics X and a former leader of Baidu's Xiaodu robot team. The legal entity is Astribot (Shenzhen) Co., Ltd. The company's defining technical bet is rope/cable-driven (tendon) actuation, which it argues yields lighter, safer, and more compliant humanoids than conventional motor-driven joints. It pursues a full-stack 'Design for AI' (DFAI) architecture that couples proprietary AI models, an embodied operating system, and the rope-driven body. Commercially, Stardust sells hardware to enterprise buyers across industrial, retail, research, and education segments, positioning itself around 'Physical AI' commercialization rather than pure research demos. Its lead products are the S1 dual-arm robot and the T1 humanoid launched in May 2026.[CO001, CO002, CO003, CO004, CO006, CO017]
How the technology, products, customers, and capital interlock, with the principal dependency.
[CO017, CO015, CO018, CO019, CO008, CO031]1.2 Founders, Leadership, and Governance
The company's public identity is tightly bound to founder, chairman, and CEO Lai Jie, whose pedigree spans Tencent Robotics X (as its first engineer) and Baidu's Xiaodu robot program, with roughly sixteen years of robotics experience reported. The founding engineering team is drawn largely from the same Tencent Robotics X cohort, and Dai Yuan is identified as a co-founder. This concentration is a strength for technical credibility but a clear key-person risk: nearly all press coverage, product narrative, and investor messaging flow through Lai Jie, and no successor, named COO, or full C-suite is publicly documented. Governance disclosure is thin - no board roster, control rights, or ownership percentages have been published, even after the Series B added multiple strategic and state-backed investors. For diligence, confirming the cap table, board composition, and any investor control or veto rights is a priority, as is mapping the depth of the technical bench beneath the founder.[CO004, CO005, CO030, CO031, CO032, CO035]
| Person | Role | Background | Founder-market fit / functional coverage | Key-person dependency |
|---|---|---|---|---|
| Lai Jie | Founder, Chairman & CEO | First engineer at Tencent Robotics X; led Baidu Xiaodu robot team; ~16 yrs robotics | Deep robotics + embodied-AI fit; owns technical and public narrative | Critical - primary public face and technical lead; no named successor |
| Dai Yuan | Co-founder | Reported co-founder from the founding team | Contributes to founding leadership | High - limited independent public profile |
| Core engineering team | Founding engineers | Largely ex-Tencent Robotics X roboticists | Hardware + AI systems depth | Moderate - concentration in an ex-Tencent cohort |
Enumeration limited to publicly named leaders as of the run date; full executive roster and board are not disclosed.
[CO004, CO005, CO030, CO031, CO032]1.3 Funding History, Valuation, and Capital Structure
Stardust Intelligence progressed rapidly through the capital stack. Chinese trackers describe an angel round led by Yunqi Partners in 2023, a Pre-A led by Matrix Partners China in 2024, and an A round with Jinqiu Capital and Ant Group, with aggregate lifetime capital estimated by aggregators at roughly $150 million. The headline event is the mid-2026 Series B, which Chinese financial media report exceeded RMB1 billion raised across three consecutive rounds within about three months, with China Renaissance acting as sole financial advisor. Disclosed Series B backers include Thundersoft, Kede Education, the Liangxi fund, the Yangzhou Longtou core-chip fund, and Zhongbo Juli. The round pushed the company's valuation past RMB10 billion (about $1.38 billion), formally granting unicorn status and reinforcing Shenzhen's embodied-AI cluster. Thundersoft's participation is notably strategic, pairing capital with operating-system, manufacturing, and channel cooperation at thousand-unit scale. Round-by-round amounts, ownership stakes, and preference terms remain undisclosed.[CO007, CO008, CO009, CO010, CO011, CO012]
| Stakeholder | Role | Control / economic importance | Diligence ask |
|---|---|---|---|
| Thundersoft | Series B strategic investor / partner | Strategic - OS, manufacturing, channel; thousand-unit cooperation | Confirm equity stake and board/observer rights |
| Kede Education | Series B strategic investor | Strategic - vocational-education channel | Clarify commercial commitments vs equity |
| Liangxi fund | Series B state-backed fund | State capital; Wuxi/Liangxi industrial ties | Confirm ticket size and conditions |
| Yangzhou Longtou core-chip fund | Series B state-backed fund | Regional industrial capital | Confirm allocation and lock-ups |
| Zhongbo Juli | Series B investor | Financial participation | Confirm ticket size |
| Yunqi Partners | Angel round lead (2023) | Early economic stake | Confirm ownership and pro-rata |
| Matrix Partners China | Pre-A lead (2024) | Early-stage stake | Confirm ownership and rights |
| Jinqiu Capital / Ant Group | A-round investors (2024) | Strategic + financial stake | Confirm strategic terms with Ant |
Investor list compiled from Chinese financial-media disclosures; ticket sizes, ownership percentages, and control rights are not public.
[CO011, CO012, CO013]1.4 Snapshot Metrics and Evidence Gaps
The supportable cover metrics are a valuation above RMB10 billion, a Series B exceeding RMB1 billion, a flagship T1 price of RMB89,900, a December 2022 founding date, and reported thousand-unit orders. Against these, the most important numbers for underwriting are simply unavailable: revenue, ARR, gross margin, unit economics, burn, runway, headcount, and a verified active-customer count are all undisclosed, consistent with a private Chinese hardware company. Traction is expressed through order announcements rather than recognized revenue, so the gap between booked orders and delivered, paid units is material. The company's valuation places it among a cohort of Chinese humanoid unicorns formed in 2025-2026, but the same period has drawn explicit bubble and overvaluation warnings from analysts and Chinese officials, which frames the snapshot with caution. Diligence should convert order announcements into a delivery and revenue schedule and obtain a data-room view of financials and headcount.[CO008, CO009, CO015, CO018, CO023, CO025]
| Metric | Value / Status | Date | Confidence | Evidence Gap |
|---|---|---|---|---|
| Valuation | > RMB10B (~$1.38B) | 2026-06 | medium | Third-party reported; no primary filing |
| Series B raised | > RMB1B (3 rounds) | 2026-06 | medium | Round-by-round split not itemized |
| Lifetime raised (est.) | ~$150M | 2026 | low | Aggregator estimate; unverified |
| Stage | Series B / unicorn | 2026-06 | medium | None material |
| T1 price | RMB89,900 | 2026-05 | medium | Configuration/options not detailed |
| Founded | December 2022 | 2022-12 | high | Confirmed by company + registry |
| Headquarters | Shenzhen, China | 2026-07 | high | Confirmed on company site |
| Founder/CEO | Lai Jie | 2026 | medium | Team roster not fully public |
| Revenue / ARR | Not disclosed | 2026-07 | n/a | Private; no financial disclosure |
| Headcount | Not disclosed | 2026-07 | n/a | No public employee count |
| Customer count | Not disclosed (thousand-unit orders) | 2026 | low | Named end-customers limited |
| Lead products | S1, T1 (rope-driven) | 2026-05 | medium | None material |
Values are the strongest publicly supportable figures as of the 2026-07-14 run date; revenue, ARR, margin, and headcount are unavailable for this private company.
[CO008, CO009, CO014, CO007, CO015, CO001]Compact investability snapshot.
[CO008, CO009, CO015, CO001, CO018, CO023]1.5 Milestones, Products, and Commercial Traction
The company's chronology accelerated sharply after its 2022 founding. The S1 dual-arm, rope-driven robot debuted at the World Robot Conference in August 2024 and went viral for arm speed and dexterity, establishing the brand internationally. Commercial proof points followed: in September 2025 SEER (Xiangong Intelligence) signed what was described as China's first thousand-unit industrial humanoid order to be delivered over two years, and in November 2025 the company signed an embodied-AI order and developer-platform partnership with Baidu and Jishu Diedai at CHTF. The T1 humanoid launched in May 2026 at RMB89,900, an aggressive price aimed at opening business, research, and education markets, targeting five scenario families spanning home service, commercial stores, research/education, tourism, and light industry. These milestones underpin the mid-2026 Series B and unicorn valuation, though the company competes in an intensely crowded Chinese humanoid market led on volume by Unitree and AgiBot.[CO016, CO019, CO022, CO015, CO028, CO018]
| Date | Event | Type | Amount / valuation / status | Participants | Implication |
|---|---|---|---|---|---|
| 2022-12 | Company founded in Shenzhen | founding | - | Lai Jie + ex-Tencent Robotics X team | Establishes rope-driven humanoid startup |
| 2023 | Angel round | financing | Undisclosed | Yunqi Partners (lead) | First institutional capital |
| 2024-08 | S1 debut at World Robot Conference | product | Demo / viral | Astribot | Global attention for arm speed and dexterity |
| 2024-2025 | Pre-A and A rounds | financing | Undisclosed | Matrix China; Jinqiu Capital; Ant Group | Scales R&D toward productization |
| 2025-09 | SEER thousand-unit industrial order | scale | ~1,000 units over 2 years | SEER (Xiangong Intelligence) | China's first thousand-unit industrial humanoid order |
| 2025-11 | CHTF embodied-AI order + dev platform | partnership | Order + strategic MOU | Baidu; Jishu Diedai | Developer-platform ecosystem play |
| 2026-05 | T1 humanoid launch | product | RMB89,900 | Astribot | Aggressive price to open B2B market |
| 2026-06 | Series B completed | financing | > RMB1B; valuation > RMB10B | Thundersoft; Kede Education; Liangxi; others; China Renaissance advisor | Unicorn status achieved |
| 2026-06 | Named among Shenzhen RMB10B embodied unicorns | governance | Valuation milestone | Shenzhen embodied-AI cluster | Reinforces regional leadership positioning |
Single chronology of record; dates and amounts reflect the strongest public disclosures. Undisclosed = amount not made public.
[CO001, CO013, CO016, CO019, CO022, CO015]Founding-to-Series-B chronology, with one adverse sector-level marker.
[CO001, CO013, CO016, CO019, CO022, CO015]1.6 Exhibits
02Market Analysis
2.1 Market Boundary and Substitutes
Stardust competes in China's market for enterprise service and light-industrial humanoid robots - bipedal or dual-arm systems sold to organizations for real tasks - a subset of the broader embodied-AI landscape. In-market spend covers general-purpose and light-industrial humanoids, education and research units, and retail/tourism service robots. Excluded from the boundary are quadruped robots (e.g., Unitree's Go line), fixed factory automation and PLC-driven cells, and standalone collaborative arms, which are treated as substitutes or adjacencies rather than direct market. The most important status-quo substitute remains human labor, followed by fixed automation and cobots for structured tasks. This boundary matters because headline 'humanoid market' figures often blend these categories; defining Stardust's addressable slice as enterprise humanoids clarifies which demand and competitors are truly relevant and prevents overstating the reachable opportunity. In practice the boundary is porous at the edges, because a buyer weighing a humanoid will also price a cobot or additional shift labor for the same task, so competing budgets extend well beyond named humanoid vendors.[CM011, CM012, CM013, CM022, CM036]
| Segment / category | Included spend | Excluded spend | Buyer / payer | Relevance |
|---|---|---|---|---|
| Service / general-purpose humanoids | Dual-arm & full humanoids for tasks | Fixed automation, PLC lines | Enterprises, institutions | Core - Stardust S1/T1 target |
| Light-industrial humanoids | Material handling, sorting, loading | Heavy fixed robotics cells | Factories, logistics | Core - SEER-type orders |
| Education / research robots | Training platforms, lab units | K-12 toy robots | Universities, vocational schools | High - Kede Education channel |
| Retail / tourism service robots | Guides, retail carts, hospitality | Kiosks, static displays | Retail chains, venues | Adjacent - emerging demand |
| Quadruped / mobile robots | - | Quadrupeds (Unitree Go) | - | Excluded - different form factor |
| Collaborative arms (cobots) | - | Standalone cobots | - | Substitute, not humanoid |
Boundary drawn around bipedal/dual-arm humanoids sold to enterprises; quadrupeds, fixed automation, and cobots are treated as substitutes/adjacencies, not in-market.
[CM011, CM012, CM013, CM022]Buyer-payer-trigger relationships across target segments.
[CM013, CM016, CM019, CM022, CM026]2.2 Market Sizing and Growth
Sizing the China humanoid market requires multiple lenses because published estimates diverge dramatically. EmbodiedGlobal cites a 2026 China figure near RMB104.7 billion, while other framings reach as high as RMB1,047 billion, and analysts describe CAGRs above 65% into the next decade. Globally, Axis Intelligence estimates 2026 sector revenue near $6.24 billion, and Goldman Sachs projects a roughly $38 billion global TAM by 2035, with longer-run banks envisioning trillion-dollar-scale markets by mid-century. On a unit basis, Morgan Stanley forecasts about 50,000 China humanoid sales in 2026. China's structural dominance is clear - about 90% of global output in 2025 and roughly 85% of shipments in 2026, with output forecast to surge about 94% year-on-year. Against these figures, Stardust's serviceable obtainable market is a small early slice measured in thousands of units near-term. The wide dispersion of estimates - a genuine RMB1,047B outlier included - is itself a material finding preserved for diligence.[CM001, CM002, CM003, CM004, CM005, CM006]
| Lens | Publisher | Year | Geography | Value | CAGR | Confidence / limitation |
|---|---|---|---|---|---|---|
| Global humanoid revenue | Axis Intelligence | 2026 | Global | ~$6.24B | >50% | Estimate; early revenue base |
| Global humanoid TAM | Goldman Sachs | 2035 | Global | ~$38B | - | Long-range forecast |
| China humanoid market | EmbodiedGlobal | 2026 | China | ~RMB104.7B | >65% | Wide divergence across sources |
| China humanoid market (outlier) | EmbodiedGlobal | 2026 | China | up to RMB1,047B | - | Outlier; methodology unclear |
| China humanoid unit sales | Morgan Stanley | 2026 | China | ~50,000 units | - | Bank estimate; near-term |
| Stardust SOM (near-term) | Report estimate | 2026 | China | thousands of units | - | Order-based; low confidence |
Multiple lenses shown because single point estimates diverge sharply; units differ by row (revenue $, market RMB, unit counts) - do not sum across rows.
[CM003, CM006, CM007, CM008, CM025, CM024]Layered sizing from global TAM down to Stardust's serviceable obtainable market.
[CM007, CM003, CM008, CM025, CM035]Low/base/high bounds for key market quantities; note the RMB1,047B outlier for the China 2026 figure.
Ranges synthesize divergent third-party estimates; CAGR row mixes market-CAGR and 2026 output-growth as an upper bound.
[CM003, CM004, CM006, CM005, CM002]2.3 Buyers, Segments, and Adoption Path
Demand originates from a diverse buyer set. Industrial and logistics operators buy to automate repetitive or dangerous material handling, funded by corporate capex; retail, tourism, and hospitality venues buy customer-facing service and differentiation; universities and labs buy research platforms on grants; and vocational schools and universities buy training units, frequently on state or institutional budgets and through channels like Kede Education. Across segments the adoption path runs from demo and showcase interest, to a paid pilot, to limited production, and only then to scaled multi-site rollout and expansion - each stage gated by demonstrated ROI. Because many deployed humanoids still operate at only 20-30% of human efficiency, conversion from pilot to scaled production is the critical bottleneck. Public showcases such as CHTF and Hong Kong's InnoEx 2026 signal rising interest, and government deployment programs shorten procurement in policy-backed verticals, but genuine production economics remain the gating factor.[CM013, CM016, CM019, CM021, CM022, CM026]
| Segment | Buyer | User | Payer | Workflow / adoption trigger |
|---|---|---|---|---|
| Industrial / logistics | Plant/ops director | Line operators | Corporate capex | Automate repetitive/dangerous material handling |
| Retail / commercial | Chain operations lead | Store staff | Marketing/ops budget | Customer-facing service, novelty, footfall |
| Tourism / hospitality | Venue manager | Guests / staff | Venue capex | Experience differentiation |
| Research | PI / lab head | Researchers | Grant / institution | Manipulation and embodied-AI research |
| Education / vocational | Dean / procurement | Students / instructors | State + institution | AI/robotics training curriculum (Kede channel) |
Budget ownership differs by segment; education and industrial buyers often draw on state or institutional capital, shortening procurement in policy-backed programs.
[CM013, CM016, CM019, CM022]Illustrative enterprise adoption funnel from demo to expansion, gated by ROI proof.
Funnel percentages are illustrative of typical enterprise robotics conversion, not company-specific data.
[CM021, CM018, CM020]2.4 Growth Drivers, Constraints, and Contested Estimates
The market's tailwinds are strong: sharp cost declines exemplified by sub-RMB90,000 humanoids, the world-first HEIS 2026 national standards, and MIIT/SASAC deployment programs that create state-backed demand. Massive capital is flowing - embodied-AI financing exceeded RMB33.5 billion in the first eleven months of 2025 (about four times the prior year), and 2026 has seen over 500 robotics financing rounds worth roughly RMB96 billion, with tech giants and carmakers entering. Yet the constraints are equally real and explicitly documented: unproven ROI, reliability, battery and safety limits, semiconductor import restrictions capping AI progress, and repeated bubble and overcapacity warnings from banks such as Morgan Stanley and from Chinese officials. National standards will reduce fragmentation but take time to adopt industry-wide. For diligence, the divergence of market estimates and the gap between order announcements and proven production ROI are the central unresolved questions, and the most bearish analyst views should be weighted, not dismissed.[CM009, CM010, CM014, CM015, CM017, CM018]
| Driver / constraint | Direction | Timing | Implication | Diligence ask |
|---|---|---|---|---|
| Sharp cost declines (sub-RMB90k units) | Driver | Now | Lowers adoption barrier, expands buyers | Verify unit economics at that price |
| National standards (HEIS 2026) | Driver | 2026+ | Safety/interoperability enable scale | Track certification requirements |
| MIIT/SASAC deployment programs | Driver | 2026 | State-backed demand and pilots | Confirm program eligibility |
| Tech-giant / carmaker entry | Mixed | 2026+ | More demand but fiercer competition | Assess competitive share loss |
| Unproven ROI (20-30% human efficiency) | Constraint | Now | Slows production-scale rollouts | Obtain deployment ROI data |
| Reliability / safety / battery limits | Constraint | Now | Confines many uses to pilots | Field-reliability evidence |
| Bubble / overcapacity risk | Constraint | 2026 | Financing and valuation risk | Stress-test demand assumptions |
| Semiconductor import limits | Constraint | Ongoing | Caps AI/compute progress | Assess chip supply exposure |
Rows mix demand tailwinds and adoption headwinds; ROI and reliability constraints are the most material near-term brakes on production-scale adoption.
[CM017, CM015, CM014, CM023, CM018, CM020]2.5 Exhibits
03Competitors
3.1 Competitive Landscape and Entrants
Stardust operates in one of the most crowded technology markets of 2026: over fifty Chinese humanoid developers plus major US players. The China market is effectively a duopoly, with Unitree and AgiBot together holding roughly 80% of domestic share. Unitree, targeting an IPO reportedly valuing it near $7 billion, combines brand strength, viral demos, and a low-cost G1 humanoid around $16,000. AgiBot (Zhiyuan) pursues mass production with heavy state and investor backing. Well-funded peers include Galbot (~$3B valuation), the listed UBTech with its Walker series, rehabilitation-rooted Fourier with its GR-series, and emerging startups such as EngineAI. Abroad, Figure AI (~$39B), 1X (Neo at ~$20,000), Apptronik (~$5.5B), and Tesla's Optimus command vast capital. Likely new entrants - tech giants such as Alibaba and ByteDance and carmakers such as BYD and XPeng - will intensify rivalry further. Against this backdrop Stardust is a comparatively small, though rapidly funded, challenger.[CP001, CP002, CP004, CP005, CP006, CP007]
| Competitor | Category | Scale / funding | Target segment | Differentiation | Limitation |
|---|---|---|---|---|---|
| Unitree | Direct China peer | ~$7B IPO target | Research, industrial, consumer | Brand, low-cost G1 (~$16k), viral demos | Quadruped roots; humanoid dexterity maturing |
| AgiBot (Zhiyuan) | Direct China peer | Well-funded, state-backed | Industrial, service | Mass production, A2 line | Crowded product line; margin pressure |
| Galbot | China peer | ~$3B valuation | Manipulation / service | Grasping AI focus | Earlier commercial traction |
| Fourier | China peer | VC-backed | Rehab, research, healthcare | Rehabilitation heritage, GR-series | Niche vs general-purpose |
| UBTech | Listed China peer | Public (HKEX) | Industrial, education | Walker series, listed capital | High cost; profitability concerns |
| Figure AI | US peer | ~$39B valuation | US industrial | Massive capital, OpenAI ties | No China presence; unproven ROI |
| 1X | US peer | Well-funded | Western home/enterprise | Neo (~$20k), consumer push | Limited scale; Western focus |
| Stardust Intelligence | Subject | ~$1.38B valuation, >RMB1B raised | Industrial, retail, education | Rope-driven actuation, full-stack DFAI, T1 (RMB89,900) | Smaller scale; unproven actuator reliability |
Profiles synthesize public valuations and product positioning as of mid-2026; valuations for private firms are third-party reported and approximate.
[CP002, CP004, CP005, CP006, CP007, CP008]Positioning on affordability (x, higher=more affordable) vs capability/full-stack strength (y).
Axes are evidence-backed ordinal scores (0-10): x=price accessibility, y=capability/full-stack maturity; not vendor benchmarks.
[CP002, CP006, CP008, CP013, CP015, CP019]3.2 Capability and Pricing Comparison
On capability, Stardust's strongest card is manipulation: its S1 demonstrated end-effector speeds up to about 10 m/s with roughly 0.1 mm repeatability, among the fastest publicly shown, and its 'Design-for-AI' full-stack pairs an AI model and embodied OS with a rope/tendon-driven body. Most rivals rely on conventional motor or harmonic-drive joints, so the actuation approach is a genuine technical differentiator. On price, the T1 at RMB89,900 sits in the affordable tier alongside Unitree's ~$16,000 G1, well below US units like 1X's ~$20,000 Neo and enterprise-only offerings from UBTech, Apptronik, and Fourier whose pricing is undisclosed. Enterprise buyers weigh dexterity, autonomy, price, reliability, and deployment support; Stardust scores well on the first three but is unproven on reliability at scale, where Unitree and AgiBot lead on mass-production maturity. The capability matrix therefore shows Stardust strong in narrow dimensions but behind incumbents on production and brand.[CP003, CP009, CP012, CP013, CP014, CP015]
| Buying criterion | Stardust | Unitree | AgiBot | Figure AI | Fourier |
|---|---|---|---|---|---|
| Manipulation dexterity / speed | High (S1 ~10 m/s) | Medium | Medium | High | Medium |
| Affordability (unit price) | High (RMB89,900) | High (~$16k G1) | Medium | Low | Low |
| Full-stack AI + OS | High (DFAI/DuoCore) | Medium | High | High | Medium |
| Mass-production maturity | Low-medium | High | High | Medium | Medium |
| Brand / distribution | Medium | High | Medium | High | Medium |
| Reliability track record | Unproven | Emerging | Emerging | Unproven | Medium |
Ordinal ratings (High/Medium/Low) are evidence-backed judgments, not vendor benchmarks; 'Unproven' marks cells lacking independent field data.
[CP003, CP013, CP015, CP016, CP017, CP027]| Product | Vendor | Price | Model | Included | Unknowns / implication |
|---|---|---|---|---|---|
| T1 | Stardust | RMB89,900 (~$12,500) | Hardware sale | Full humanoid, 23 DoF | Service/warranty terms undisclosed |
| G1 | Unitree | ~$16,000 | Hardware sale | Compact humanoid | Payload lower than industrial units |
| Neo | 1X | ~$20,000 | Preorder/hardware | Home humanoid | Western market; limited China relevance |
| Walker S | UBTech | Enterprise (undisclosed) | B2B contract | Industrial humanoid | High cost; project-based pricing |
| Apollo | Apptronik | Enterprise (undisclosed) | B2B/lease | Industrial humanoid | US-focused; pricing opaque |
| GR-series | Fourier | Undisclosed | Research/B2B | Research humanoid | Niche pricing; not mass-market |
Prices mix retail and enterprise/undisclosed models; T1 and G1 anchor the affordable tier while US and enterprise units carry opaque, higher pricing.
[CP003, CP009, CP015, CP031]Capability coverage and strength across five leading humanoid makers.
[CP003, CP013, CP016, CP027, CP035]3.3 Moat, Switching Costs, and Durability
Stardust's moat is real but narrow. Its actuator know-how and full-stack integration are meaningful today, yet both are replicable by better-capitalized rivals over time, and the sector is commoditizing as suppliers share actuators, sensors, and AI toolkits and as national standards reduce differentiation across the field. Switching costs for buyers are moderate - integration, safety certification, and retraining create some lock-in, but enterprises can multi-home across vendors, and internal build or continued human labor remain default alternatives for cost-sensitive customers. Potential durable advantages would come from a developer ecosystem around the DuoCore OS or from proven reliability at scale, but neither is established today. Crucially, Stardust trails Unitree and AgiBot on scale, funding, and production maturity, and its dexterity leadership remains demo-stage rather than field-validated. The competitive verdict is that Stardust holds a defensible wedge on affordability plus full-stack design, but its moat durability is contingent on execution and on proving that rope-driven actuators are reliable in real, sustained commercial deployments rather than showcase demonstrations.[CP018, CP019, CP021, CP022, CP023, CP029]
| Moat claim | Threat | Severity | Mitigation / diligence ask |
|---|---|---|---|
| Rope-driven actuator know-how | Rivals replicate or bypass with better motors | High | Verify patent coverage and reliability data |
| Full-stack DFAI (model+OS+body) | Larger firms out-invest in AI stack | High | Assess AI-model benchmarks vs peers |
| Affordability / cost leadership | Unitree/AgiBot match sub-RMB100k pricing | High | Confirm BOM cost and gross margin |
| S1 dexterity/speed leadership | Demo-stage; reliability unproven at scale | Medium | Obtain field-reliability and MTBF data |
| Developer-ecosystem lock-in | Ecosystem not yet established | Medium | Track third-party app and SDK adoption |
| Brand from viral S1 demos | Unitree brand and share far larger | Medium | Measure inbound demand and win rates |
Rows ordered by severity; every claimed moat is judged replicable by better-capitalized rivals, so durability is contingent on execution and reliability proof.
[CP012, CP014, CP019, CP022, CP023, CP024]Compact competitive durability snapshot.
[CP001, CP002, CP015, CP013, CP022]3.4 Distribution Power, Likely Entrants, and Displacement Risk
Beyond today's field, distribution power and new entrants shape the competitive trajectory. Unitree's brand recognition and viral demonstrations grant it distribution and mindshare advantages that Stardust, despite its own attention-grabbing S1 debut at WRC 2024, does not match. All Chinese players benefit from a dense domestic supply chain that keeps costs low, so cost advantage alone is not proprietary. The most consequential future threats are well-resourced entrants: tech giants such as Alibaba and ByteDance and carmakers such as BYD and XPeng are moving into humanoid robotics, bringing manufacturing scale, capital, and existing enterprise relationships. Displacement risk is therefore high - as sub-RMB100,000 humanoids proliferate and shared toolkits converge feature sets, a smaller specialist like Stardust could be squeezed between the incumbent duopoly above and a wave of deep-pocketed entrants. Its best defense is to convert early dexterity and cost leadership into either a sticky developer ecosystem or a demonstrable, independently verified reliability advantage before parity erases its wedge.[CP020, CP021, CP024, CP025, CP033, CP034]
3.5 Exhibits
04Financials
4.1 Revenue Streams and Monetization
Stardust monetizes primarily through one-time hardware sales: the T1 humanoid at RMB89,900, the higher-priced S1 research system (estimated $100,000-150,000), multi-unit enterprise and industrial contracts, an education channel via Kede Education, and a nascent developer-platform track seeded by a CHTF MOU. Critically, the company discloses no revenue, so every stream is characterized by status signals rather than financials. The clearest traction signal is a first-of-its-kind thousand-unit industrial humanoid order from SEER in September 2025, plus additional orders at CHTF, and deployment across roughly six Chinese cities. But order announcements are not recognized revenue: recognition on large multi-unit deals carries timing risk tied to delivery, acceptance, and deployment milestones, and long enterprise sales cycles mean bookings may convert to revenue slowly. Revenue mix is inferred to skew heavily toward hardware today, with education and software revenue immaterial. For diligence, converting the headline order signals into verified shipped-unit revenue and average selling prices is the first priority.[CI004, CI005, CI009, CI010, CI014, CI015]
| Stream | Mechanism | Unit | Current value / status | Quality | Diligence ask |
|---|---|---|---|---|---|
| T1 hardware sales | One-time hardware sale | Per robot (RMB89,900) | Launched May 2026; orders reported | Undisclosed revenue | Obtain units shipped and ASP realized |
| S1 research systems | Hardware sale to labs | Per system (~$100-150k) | Selling since 2024 | Undisclosed | Confirm S1 unit sales |
| Enterprise / industrial orders | Multi-unit contracts | Per order | Thousand-unit SEER order (2025) | Order signal only | Verify order conversion to revenue |
| Education channel | Institutional sales | Per unit / program | Kede Education partnership | Nascent | Quantify education revenue |
| Developer platform / software | Platform / MOU | TBD | CHTF MOU (2025) | Pre-revenue | Assess software monetization plan |
Streams inferred from public product, order, and partnership signals; no stream has disclosed revenue, so all values are status indicators rather than financials.
[CI004, CI005, CI009, CI010, CI014, CI015]| Product | List price | Realized pricing | Model | Discounts / unknowns | Source |
|---|---|---|---|---|---|
| T1 | RMB89,900 (~$12,500) | Undisclosed | One-time hardware sale | Volume/enterprise discounts unknown | Netease / vendor |
| S1 | ~$100,000-150,000 (est.) | Undisclosed | Research/B2B sale | Estimate only; not official list | Third-party specs |
| Enterprise multi-unit | Negotiated | Undisclosed | Contract / project | Order pricing opaque | SEER order reports |
| Education units | Undisclosed | Undisclosed | Institutional / program | Subsidy-linked pricing possible | Kede channel reports |
List price is public only for the T1; all realized and enterprise pricing is undisclosed, so monetization economics cannot yet be verified.
[CI002, CI005, CI025, CI027]How customer activity converts to revenue and gross profit; monetary values undisclosed.
All monetary nodes are qualitative because Stardust discloses no revenue or cost figures.
[CI004, CI014, CI015, CI016, CI034]4.2 Unit Economics and Margin Risk
The financial heart of the Stardust question is whether a humanoid can be sold profitably at RMB89,900. No gross margin, bill-of-materials cost, CAC, or per-unit service cost is disclosed, so nearly every unit-economics metric is null. The aggressive sub-RMB90,000 price - a deliberate market-expansion move enabled by China's dense, low-cost supply chain - raises a direct margin-sustainability question, because humanoid bill-of-materials costs remain high and global supply-chain constraints could push component prices up during scale-up. Deployed robots also require ongoing service and support, adding to cost of delivery, and sector analysts stress that humanoid unit economics are unproven industry-wide, with ROI contingent on effective real-world output. The only external anchor is listed peer UBTech, whose public financials show humanoid makers running losses despite high valuations. The reasonable base case is that Stardust's near-term contribution margins are thin or negative, funded by equity rather than operations - a hypothesis diligence must test against an actual margin bridge.[CI006, CI012, CI016, CI018, CI027, CI031]
| Metric | Value / null | Confidence | Why it matters | Diligence ask |
|---|---|---|---|---|
| Gross margin | null (undisclosed) | - | Determines profitability at RMB89,900 | Request BOM and margin bridge |
| T1 BOM cost | null | - | Sets floor under aggressive pricing | Obtain component cost breakdown |
| CAC / payback | null | - | Enterprise sales efficiency | Provide deal-level economics |
| Service cost per unit | null | - | Post-sale support drag | Share maintenance cost data |
| Revenue per robot | null | - | Core unit revenue | Disclose ASP realized |
| Comparable (UBTech) margins | Loss-making (listed) | medium | Sector profitability benchmark | Compare to peer disclosures |
Nearly every unit-economics metric is null because Stardust discloses none; the only anchor is listed peer UBTech showing humanoid makers run losses.
[CI006, CI012, CI016, CI018, CI031, CI034]Qualitative unit-economics bridge from T1 price to contribution margin.
Inputs unavailable; nodes are qualitative with margin flagged as unproven given aggressive pricing.
[CI012, CI027, CI034, CI036]4.3 Capital Adequacy, Burn, and Financing Dependency
Stardust's capital position is its strongest financial fact. As detailed in the Company Overview funding chronology, it raised more than RMB1 billion across three consecutive Series B rounds (B, B+, B++) in roughly three months in mid-2026, reaching a valuation above RMB10 billion (~$1.38B), atop an estimated $150 million lifetime raise, with a syndicate including Thundersoft, Kede Education, Liangxi Fund, a Yangzhou core-chip fund, and Zhongbo Juli, advised by China Renaissance. Proceeds are earmarked for mass production, R&D, and go-to-market. Yet cash on hand, monthly burn, and runway are all undisclosed, and no debt or project finance is evident, so the company appears equity-funded. Capital intensity is real: a Wuxi (Liangxi) mass-production build-out implies meaningful capex and working-capital needs, potentially partly offset by municipal subsidies. The rapid three-round raise signals strong investor demand but also aggressive planned capital consumption; the likely next-round trigger is hitting Wuxi production and revenue milestones. Because sector-wide bubble and overcapacity warnings could tighten future capital access, financing durability is a material - and currently unquantifiable - risk.[CI001, CI003, CI007, CI008, CI011, CI013]
| Item | Value / status | Notes |
|---|---|---|
| Total raised (lifetime) | ~$150M (est.) | Angel to Series B; aggregator estimate |
| Series B rounds | 3 rounds, >RMB1B, mid-2026 | Series B / B+ / B++ in ~3 months |
| Valuation | >RMB10B (~$1.38B) | Unicorn status mid-2026 |
| Cash on hand | Undisclosed | Not public |
| Monthly burn | Undisclosed | Not public |
| Runway | Undisclosed | Not public |
| Planned use of funds | Mass production, R&D, GTM | Per company statements |
| Next-round trigger | Wuxi production / revenue milestones | Inferred |
| Debt / project finance | None evident (equity-funded) | No public debt disclosure |
Refers to the Company Overview funding chronology in prose; capital base is strong but cash, burn, and runway are undisclosed, so financing durability cannot be quantified.
[CI001, CI003, CI007, CI008, CI021, CI022]Source-backed ranges for capital and valuation; revenue and burn omitted as unestimable.
Revenue/burn ranges intentionally excluded - no public basis exists to bound them.
[CI001, CI003, CI029]Where equity capital flows: R&D, manufacturing capex, working capital, and deployment.
Cash-flow magnitudes are qualitative; only capital raised is quantified.
[CI007, CI011, CI013, CI028, CI036]4.4 Financial Verdict and Diligence Blockers
The financial verdict is that Stardust is capital-rich but revenue-opaque. Public evidence confirms a strong equity base, an aggressive T1 price, and genuine order signals, but it cannot establish revenue, margins, burn, runway, or customer-level economics - all of which are undisclosed. The valuation-to-revenue relationship is therefore unmeasurable, the single most important diligence blocker. Financing facts are current to mid-2026 and are the freshest available, but they describe capital raised, not capital efficiency. The investment case rests almost entirely on unproven unit economics and on the company's ability to execute manufacturing scale-up in Wuxi while defending margins against a sub-RMB90,000 price point. Diligence must obtain audited financials, a BOM and gross-margin bridge, shipment and acceptance data behind the order signals, deal-level CAC/payback, and a capex schedule. Until then, the financial profile should be treated as high-risk and evidence-light, consistent with an early-stage hardware company priced on future potential rather than demonstrated economics.[CI006, CI026, CI030, CI032, CI034, CI035]
| Missing private metric | Impact | Diligence path |
|---|---|---|
| Revenue / ARR | Cannot assess scale or valuation multiple | Request audited financials |
| Gross margin | Cannot judge profitability at T1 price | Obtain BOM and margin bridge |
| Burn / runway | Cannot assess financing risk | Request cash-flow statements |
| Units shipped | Order signals unverified as revenue | Obtain shipment and acceptance data |
| Customer-level economics | CAC/LTV unknown | Provide deal-level P&L |
| Capex schedule (Wuxi) | Capital intensity unclear | Share manufacturing capex plan |
Gaps are pervasive; the report can verify capital raised and pricing but not revenue, margins, or cash dynamics without management disclosure.
[CI006, CI032, CI035, CI011, CI031]4.5 Exhibits
05Product & Technology
5.1 Product Definition and Portfolio
Stardust builds general-purpose humanoid robots that perform physical tasks in customer workflows. Its portfolio centers on two hardware platforms plus a software stack. The S1, a dual-arm wheeled system with 7-DoF arms and roughly 5 kg per-arm payload, debuted at the World Robot Conference in August 2024 and drew global attention by demonstrating end-effector speeds up to about 10 m/s with roughly 0.1 mm repeatability - exceptional dexterity for a humanoid-class manipulator. The T1, launched in May 2026 at RMB89,900, is a full humanoid standing about 1.53-1.55m, weighing around 66kg, with 23 degrees of freedom and roughly 5 kg per-arm payload, positioned for light manipulation across home, commercial, research/education, tourism, and light-industrial scenarios rather than heavy industrial loads. Above the hardware sits a 'Design-for-AI' software stack - the Lumo AI model for perception, planning, and manipulation and the DuoCore embodied OS, which the company positions as a platform for third-party applications. Product maturity is highest for the demonstrated S1 and the core actuators, and earliest-stage for T1 reliability at scale and the benchmarked capability of the AI layer.[CE001, CE002, CE003, CE005, CE006, CE007]
| Module / product | User | Status / maturity | Differentiation | Diligence gap |
|---|---|---|---|---|
| S1 dual-arm system | Researchers, service ops | Demonstrated since 2024 | Rope-driven, ~10 m/s, ±0.1mm | At-scale reliability data |
| T1 humanoid | Enterprise, education, consumer | Launched May 2026 | 23 DoF, RMB89,900 price | Field durability of 23-DoF body |
| Lumo AI model | Autonomy stack | Company-claimed | Embodied intelligence layer | Benchmarked capability undisclosed |
| DuoCore embodied OS | Developers, integrators | Company-claimed / platform | OS for third-party apps | Ecosystem adoption evidence |
| Rope-driven actuators | Hardware subsystem | Core, demonstrated | Lightweight, compliant limbs | Cable wear / MTBF data |
Maturity spans demonstrated (S1, actuators) to newly launched (T1) to company-claimed (AI/OS); gaps cluster on at-scale reliability and undisclosed AI benchmarks.
[CE001, CE002, CE003, CE005, CE008, CE009]| User job | Current workflow | Stardust solution | Measurable benefit | Limitation |
|---|---|---|---|---|
| Light manipulation / handling | Human labor or fixed arms | T1/S1 dexterous manipulation | ~5 kg/arm, high-speed motion | Not for heavy loads |
| Research on embodied AI | Custom lab rigs | S1 research platform | Fast, precise manipulation testbed | High cost (~$100-150k) |
| Education / training | Textbooks, sim | T1 education units | Hands-on AI/robotics learning | Curriculum integration effort |
| Retail / tourism service | Static kiosks, staff | T1 commercial mode | Customer engagement, novelty | ROI unproven |
| Light-industrial tasks | Manual / cobots | T1 industrial scenario | Automates repetitive tasks | Reliability at scale unproven |
Use cases span research, education, service, and light industry; measurable benefits rest on demonstrated dexterity, but several deployments have unproven ROI.
[CE006, CE007, CE016, CE022, CE028]How a customer deploys and operates a Stardust humanoid from scoping to expansion.
[CE007, CE022, CE009, CE016]5.2 Architecture and the Rope-Driven Differentiator
The defining technical choice is rope/cable-driven (tendon-driven) actuation. Instead of placing heavy motors and gearboxes at each joint, Stardust relocates motors into the torso and transmits force through cables to the limbs. This lowers limb inertia, enabling the high speeds and compliance the S1 showcased, and can improve human-robot interaction safety because lighter, lower-inertia limbs are less dangerous on contact. Most competitors - including Unitree's G1 and Fourier's GR-series - rely on conventional motor or harmonic-drive joints, so the approach is a genuine differentiator and the heart of Stardust's IP and know-how, though public patent breadth is not detailed. The full stack layers the Lumo AI model and DuoCore OS above this body, with a public GitHub presence signaling intent to cultivate a developer ecosystem. The critical caveat is reliability: complex tendon routing and cable wear are recognized engineering challenges, and the long-term durability and maintenance burden of rope-driven actuators under sustained commercial load are not independently validated. Dexterity leadership is real in demonstrations but has not been proven in standardized, independent benchmarks.[CE003, CE004, CE008, CE009, CE010, CE011]
| Layer / component | Role | Dependency | Risk |
|---|---|---|---|
| AI model (Lumo) | Perception, planning, autonomy | AI compute / chips | Benchmarked capability undisclosed |
| Embodied OS (DuoCore) | Robot control + app platform | Developer ecosystem | Adoption unproven |
| Rope-driven actuators | Force transmission to joints | Cable/actuator suppliers | Cable wear, reliability |
| Sensing suite | Vision, force, proprioception | Sensor suppliers | Supply and calibration |
| Manufacturing (Wuxi) | Mass production of T1 | Capex, supply chain | Scale-up execution |
| Developer tooling (GitHub) | SDKs, examples | Community engagement | Early-stage ecosystem |
Architecture spans AI, OS, actuation, sensing, and manufacturing; the most acute risks are actuator reliability and dependence on AI-compute supply amid export limits.
[CE008, CE009, CE011, CE017, CE018, CE023]DFAI full stack from application scenarios down to rope-driven actuation hardware.
[CE003, CE004, CE009, CE017, CE027]Critical suppliers, compute, and manufacturing dependencies feeding the product and deployments.
[CE017, CE018, CE012, CE026]5.3 Deployment, Roadmap, and Manufacturing
Deploying a Stardust humanoid follows a repeatable operating flow: scope the task or scenario, integrate and configure the robot on site, complete safety validation and operator training, run autonomous operation through the Lumo/DuoCore stack, perform ongoing maintenance and actuator servicing, and expand to more units or sites once value is proven. The roadmap runs from the S1 research debut (2024) to the T1 mass-market launch (May 2026) to production scale-up at a Wuxi (Liangxi) facility in 2026 - a step whose execution will test whether the affordable RMB89,900 price, enabled by design simplification and China's dense component supply chain, can be sustained at volume. The T1's 23-DoF full-humanoid form is inherently more complex to manufacture reliably than the S1's wheeled dual-arm base, raising execution risk. Critical dependencies span actuator and cable suppliers, sensors, the domestic robotics supply chain, and AI compute - the last exposed to semiconductor export restrictions affecting Chinese robotics. Manufacturing scale-up and supply resilience are therefore the near-term technology-execution questions.[CE012, CE013, CE017, CE018, CE022, CE026]
| Date / stage | Feature / milestone | Status | Implication | Source |
|---|---|---|---|---|
| Aug 2024 | S1 debut at WRC | Complete | Established dexterity reputation | Pandaily |
| May 2026 | T1 mass-market launch (RMB89,900) | Complete | Entered affordable humanoid tier | Vendor / news |
| 2026 | Wuxi mass-production scale-up | In progress | Tests manufacturing execution | Shenzhen News |
| 2026 | HEIS standards compliance | Emerging | Shapes safety requirements | SESEC |
| Ongoing | Developer platform / ecosystem | Early | Potential lock-in if adopted | GitHub / CHTF MOU |
Roadmap moves from research demonstration to mass-market launch to production scale-up; execution on Wuxi manufacturing and standards compliance is the near-term test.
[CE006, CE012, CE013, CE014, CE023]Maturity, differentiation, and reliability evidence across product modules.
[CE010, CE020, CE021, CE031, CE035]5.4 Trust, Safety, Compliance, and Verdict
Trust and safety evidence is thinner than the capability story. China's HEIS 2026 national standards set emerging safety and interoperability requirements applicable to Stardust, and Shenzhen's 2026 introduction of embodied-AI liability insurance signals a maturing compliance framework for humanoid deployment. Rope-driven design plausibly aids interaction safety through lower-inertia limbs, and safety controls must address collision avoidance and force limiting. However, company-specific evidence is scarce: certifications, safety-test results, actuator MTBF, and data/privacy policies are all undisclosed, and quality-and-compliance disclosure is a material gap. The product/technology verdict is therefore two-sided: Stardust has genuine, demonstrated dexterity leadership and a distinctive, defensible-looking actuation approach, offset by unproven at-scale reliability, an undisclosed AI-benchmark record, and thin compliance transparency. Technical diligence should prioritize independent reliability and dexterity benchmarking, actuator durability data, AI-model evaluation, and evidence of standards certification before relying on the technology claims.[CE014, CE015, CE021, CE024, CE029, CE034]
| Control / standard | Status | Scope | Gap |
|---|---|---|---|
| HEIS 2026 national standards | Emerging (2026) | Humanoid safety/interoperability | Certification evidence undisclosed |
| Shenzhen embodied-AI liability insurance | Available (2026) | Deployment liability | Coverage terms unclear |
| Collision avoidance / force limiting | Design intent | Human-robot interaction | No published safety test data |
| Actuator reliability (MTBF) | Undisclosed | Rope-driven joints | No field durability data |
| Product certifications | Undisclosed | Regulatory approvals | Certifications not public |
| Data / privacy controls | Undisclosed | Onboard sensing/data | Policies not public |
Compliance rests on emerging national standards and new insurance mechanisms, but company-specific certification, safety-test, and reliability evidence is not public.
[CE014, CE015, CE029, CE030, CE034]5.5 Exhibits
06Customers
6.1 Customer Base and Segmentation
Stardust's customers cluster in three primary segments plus research and developer channels. Industrial and logistics buyers - exemplified by SEER - purchase for material handling and repetitive tasks, funded by corporate capex, and represent the most concrete, largest-scale demand to date. Retail and commercial buyers deploy T1 units for customer-facing service across multiple cities, though named accounts are limited and reported at the scenario level. Education and vocational buyers acquire training units through the Kede Education channel, drawing on institutional or state budgets for recurring but modest per-unit demand, while research buyers purchase the S1 as a manipulation testbed. A fifth, nascent channel is developers and integrators reached via the CHTF developer-platform MOU. Across segments, buyer, user, and payer frequently differ - a school's procurement office, its students, and a state budget, for instance - which lengthens sales cycles. Government and municipal programs in Wuxi and Shenzhen further shape the pipeline through scenario funding. The company reports deployment across roughly six Chinese cities, indicating operational breadth even where per-site depth is unclear.[CU001, CU006, CU011, CU012, CU013, CU019]
| Segment | Buyer / user / payer | Use case | Scale | Revenue / strategic value | Gap |
|---|---|---|---|---|---|
| Industrial / logistics | Plant ops / operators / corporate capex | Material handling, repetitive tasks | Thousand-unit SEER order | High strategic value | End-user outcomes undisclosed |
| Retail / commercial | Ops lead / staff / marketing budget | Customer-facing service | Multi-city, scenario-level | Medium; brand/novelty | Named accounts limited |
| Education / vocational | Dean / students / state+institution | AI/robotics training | Kede channel | Recurring institutional demand | Per-unit revenue modest |
| Research | PI / researchers / grants | Manipulation research (S1) | Niche | Reference value | Small volume |
| Developers / partners | Firms via MOU / integrators / partner | Platform apps | CHTF MOU (Baidu, Jishu Diedai) | Ecosystem option | Adoption unproven |
Segmentation shows distinct buyer/user/payer splits across industrial, retail, education, research, and partner channels; strategic value is highest in industrial but outcome evidence is thin.
[CU001, CU006, CU011, CU019, CU029, CU033]Compact customer-traction snapshot: strong order signals, weak retention/outcome evidence.
[CU001, CU003, CU002, CU009, CU027]6.2 Adoption Trajectory and Named Proof
Adoption has progressed from visibility to orders to launch. The S1's WRC 2024 debut generated global interest; in September 2025 SEER (Xiangong) placed what is reported as China's first thousand-unit-scale humanoid order, a landmark industrial demand signal; at CHTF in November 2025 Stardust secured additional orders and a developer-platform MOU involving Baidu and Jishu Diedai; and in May 2026 the T1 launched at RMB89,900. The strongest named proof is therefore the SEER order, supplemented by the Kede Education channel and the CHTF partnerships. However, the reference quality of these proofs is moderate: they are press-reported orders and MOUs rather than independently verified production deployments with quantified outcomes. Named end-user identities, production-versus-pilot status, and measurable results (productivity, cost savings) behind the headline order figures are largely undisclosed. Prudent diligence treats the thousand-unit figure as a bookings signal pending delivery and acceptance, and seeks evidence of how much of the reported demand has converted into deployed, revenue-generating units.[CU002, CU003, CU004, CU005, CU007, CU015]
| Metric | Value | Date | Source | Confidence | Implication / missing denominator |
|---|---|---|---|---|---|
| S1 public debut | WRC showcase | Aug 2024 | Pandaily | medium | Interest, not orders |
| SEER industrial order | ~1,000 units | Sep 2025 | Zhongzheng/Aibang | medium | Bookings; delivery not confirmed |
| CHTF orders + MOU | Orders + platform MOU | Nov 2025 | 21jingji | medium | Order value undisclosed |
| T1 launch | RMB89,900 | May 2026 | Netease | medium | Units sold undisclosed |
| City deployments | ~6 cities | 2026 | Leaderobot | low | Per-site utilization unknown |
Trajectory rises from 2024 showcase to 2025 orders to 2026 launch and multi-city deployment; every metric lacks a revenue or delivered-unit denominator.
[CU002, CU003, CU005, CU007, CU024]| Customer | Segment | Deployment / use case | Production vs pilot | Outcome | Limitation |
|---|---|---|---|---|---|
| SEER (Xiangong) | Industrial / logistics | ~1,000-unit humanoid order for material handling | Order (delivery in progress) | China's first thousand-unit humanoid order | End-user outcomes undisclosed |
| Kede Education | Education | Distribution channel for education units | Channel partner | Recurring institutional demand | Per-unit revenue modest |
| Baidu (via CHTF MOU) | Developer platform | Dev-platform collaboration MOU | MOU / partnership | Ecosystem development intent | Non-binding; scope unclear |
| Jishu Diedai | Developer platform | Dev-platform MOU participant | MOU / partnership | Platform ecosystem signal | Early-stage |
Named proofs are press-reported orders, channel partnerships, and CHTF developer MOUs; production status and outcomes are not independently verified.
[CU003, CU005, CU006, CU016, CU017]Customer journey from showcase discovery through multi-unit order to expansion.
[CU009, CU014, CU015, CU022, CU024]Evidence quality, production maturity, and outcome specificity across named proofs.
[CU003, CU008, CU017, CU018, CU027]6.3 Retention, Expansion, and Concentration
Evidence on durability is the weakest part of the customer picture. No public retention, repeat-purchase, churn, utilization, or satisfaction metrics exist - unsurprising for a young private hardware company, but a material gap nonetheless. Repeat and expansion orders beyond the initial announcements are not yet documented, so land-and-expand potential remains a hypothesis: it exists if pilots convert to multi-site production, but conversion evidence is pending. Meanwhile, concentration risk is real. A small number of marquee orders, above all SEER, dominate visible demand, making early revenue lumpy and dependent on individual deals converting and delivering. Go-to-market also concentrates on partner channels - the SEER distributor relationship and the Kede education channel - adding channel dependence, while the developer MOUs are non-binding and their uptake is unproven. The key unproven step across the whole base is the adoption-funnel conversion from showcase interest and pilots to sustained, repeat production deployments, precisely where sector analysts warn that humanoid orders can outrun demonstrated ROI.[CU009, CU010, CU016, CU021, CU022, CU023]
| Metric | Value / null | Segment | Confidence | Diligence ask |
|---|---|---|---|---|
| Net revenue retention (NRR) | null | All | - | Request cohort revenue data |
| Gross retention / churn | null | All | - | Obtain renewal/churn logs |
| Repeat purchase | null (not documented) | Industrial | - | Confirm follow-on orders |
| Utilization per unit | null | All | - | Share deployment telemetry |
| Customer satisfaction / NPS | null | All | - | Provide reference calls |
Retention and satisfaction metrics are entirely undisclosed; the company is too early and private to show cohort or renewal evidence, a material diligence gap.
[CU009, CU021, CU022, CU027]| Expansion driver | Concentration risk | Impact | Diligence path |
|---|---|---|---|
| Pilot-to-production conversion | Few marquee orders (SEER) dominate | Lumpy, deal-dependent revenue | Verify pipeline diversity |
| Multi-site rollout | Single distributor channel (SEER) | Channel dependence | Assess direct vs channel mix |
| Education channel scale | Reliance on Kede partnership | Partner-dependent demand | Review channel agreements |
| Developer ecosystem | MOUs non-binding | Uncertain platform uptake | Track SDK/app adoption |
| Government programs | Policy-driven demand | Exposure to program changes | Confirm program eligibility |
Expansion depends on converting pilots and channels into repeat multi-site demand, while concentration in a few orders and partners makes early revenue lumpy and dependent.
[CU011, CU022, CU028, CU036]Illustrative adoption funnel from showcase interest to expansion, gated by ROI proof.
Funnel percentages are illustrative of enterprise robotics conversion, not company-disclosed data.
[CU023, CU024, CU034, CU010]6.4 Customer Verdict
The customer verdict is that Stardust has generated genuinely strong early demand signals but has thin evidence of durable, productive adoption. On the positive side, the SEER thousand-unit order is a real, first-of-its-kind industrial milestone, multi-city deployment shows operational breadth, and the education and developer channels provide diversification options within a supportive, policy-backed Chinese demand environment. On the cautious side, named production deployments, retention, repeat purchase, and quantified customer outcomes are all undisclosed; demand is concentrated in a few marquee deals and partner channels; and the critical pilot-to-production conversion is unproven. Customer evidence is fresh - current to late-2025 and mid-2026 - but describes bookings and announcements more than delivered, sustained value. Diligence should prioritize verifying delivered units against order headlines, obtaining named-customer references and outcome data, assessing pipeline and channel diversification, and securing any available cohort or repeat-order evidence before crediting the traction narrative in full.[CU008, CU024, CU026, CU027, CU031, CU032]
6.5 Exhibits
07Risks
7.1 Regulatory, Legal, and Geopolitical Risk
Regulatory and legal exposure is a top-tier risk with a distinctive geopolitical edge. Domestically, China released the world-first HEIS 2026 national standards for humanoid robots and embodied AI, which legitimize the sector but impose certification effort and compliance cost during scale-up; China's Civil Code creates product-liability exposure for defective robots, partly mitigated by Shenzhen's new embodied-AI liability insurance; and an evolving AI-governance regime, including a draft AI law, may add future obligations. The sharper risk is external: US lawmakers introduced legislation - a House Select Committee bill and the American Security Robotics Act - to ban or restrict government purchases of Chinese humanoid robots, and the proposed GUARD Act would extend the FCC covered-list framework to robotics. These measures reflect rising strategic-security scrutiny of Chinese robots and could cap Stardust's international expansion, narrowing its addressable market. Standards fragmentation between China and international regimes could further raise export-compliance friction. The assessment is current to mid-2026 and reflects the latest standards and legislative activity.[CR001, CR002, CR003, CR015, CR016, CR017]
| Rule / license / case | Jurisdiction | Status | Likelihood | Severity | Mitigation | Residual exposure |
|---|---|---|---|---|---|---|
| US ban on Chinese robots (House bill, ASRA) | United States | Proposed 2026 | Medium | High | Focus on China market | High - caps US expansion |
| GUARD Act (FCC covered-list to robotics) | United States | Proposed 2026 | Medium | High | Monitor legislation | High - market access |
| HEIS 2026 national standards | China | Emerging 2026 | High | Medium | Standards alignment | Medium - compliance cost |
| Product liability (Civil Code) | China | In force | Medium | Medium | Liability insurance | Medium - defect claims |
| Draft AI law / governance | China | Draft | Medium | Medium | Compliance tracking | Medium - future obligations |
| Shenzhen embodied-AI liability insurance | China (Shenzhen) | Available 2026 | High | Low | Adopt coverage | Low - mitigant available |
Rules and cases span China standards/liability regimes and US legislative proposals; ordered by severity of market/compliance impact.
[CR001, CR002, CR003, CR015, CR016, CR017]Critical supplier, investor, and customer/channel dependencies around Stardust.
[CR006, CR010, CR011, CR020]7.2 Operational, Quality, and Safety Risk
Operational risk centers on the very technology that differentiates Stardust. Rope/cable-driven actuator reliability at sustained commercial scale is unproven and is the single most material technology risk; cable wear and complex tendon routing are recognized engineering challenges that could raise maintenance and failure rates, and no public MTBF or field-failure data exists. Manufacturing scale-up at the new Wuxi facility carries execution, yield, and working-capital risk, compounded by reliance on a single flagship facility for continuity. Human-robot-interaction safety - collision and force risks in public and commercial settings - requires robust controls, partly aided by the lower inertia of compliant rope-driven limbs but unsupported by published safety-test data. Quality and certification evidence is also undisclosed. Ranked by severity, actuator failure at scale (critical impact, low mitigation maturity) and a Wuxi ramp shortfall (high impact) are the leading operational exposures, both with immature mitigations and material-to-high residual risk.[CR004, CR005, CR012, CR018, CR033]
| Failure mode | Likelihood | Severity | Mitigation maturity | Residual exposure | Unresolved gap |
|---|---|---|---|---|---|
| Rope-driven actuator failure at scale | Medium | Critical | Low (demo-only) | High | No MTBF/field data |
| Wuxi manufacturing ramp shortfall | Medium | High | Low (new facility) | High | No yield data |
| Cable wear / high maintenance | Medium | High | Low | Medium-high | Durability unproven |
| Human-robot-interaction safety incident | Low-medium | High | Medium (compliant limbs) | Medium | No safety-test data |
| Single-facility continuity | Low | High | Low | Medium | No backup capacity |
| Quality/certification shortfall | Medium | Medium | Low | Medium | Certifications undisclosed |
Rows ordered by severity; actuator reliability and manufacturing ramp are the highest-severity operational exposures with the least mature mitigations.
[CR004, CR005, CR012, CR018, CR033]Likelihood, impact, and mitigation maturity across the top risk categories.
[CR004, CR009, CR007, CR023, CR010, CR013]7.3 Financial, Partner, and People Risk
Financial-model risk is high. Undisclosed revenue and margins against a sub-RMB90,000 price point imply potentially thin or negative unit economics, while sector-wide bubble and overcapacity warnings - with investors explicitly flagging humanoid robotics as a possible next AI bubble - threaten future capital access and could trigger margin-compressing price wars. Partner and dependency risk is concentrated: a few marquee orders, above all SEER, dominate visible demand; go-to-market leans on partner channels (SEER, Kede Education); AI-compute and chip supply is exposed to export restrictions; and strategic-investor reliance on Thundersoft adds continuity risk. People and execution risk includes founder key-person concentration around Lai Jie, whose robotics vision and Tencent-derived credibility anchor the company, thinly documented technical-team credentials, and unproven mass-manufacturing execution - with little public evidence of bench-depth or succession mitigation. Across these categories, risks transmit into the thesis through weak revenue, compressed margins, constrained financing, and ultimately valuation multiple compression.[CR007, CR008, CR009, CR010, CR011, CR013]
| Dependency | Counterparty | Role | Concentration | Failure scenario | Severity | Residual exposure |
|---|---|---|---|---|---|---|
| Marquee customer | SEER (Xiangong) | Largest order / channel | High | Order not delivered/repeated | High | High |
| Education channel | Kede Education | Distribution | Medium | Channel underperforms | Medium | Medium |
| Strategic investor | Thundersoft | Capital + OS/mfg support | Medium | Support withdrawn | Medium | Medium |
| AI compute / chips | Chip suppliers | Compute for AI stack | High | Export restrictions bite | High | High |
| Actuator/cable suppliers | Component vendors | Core hardware | Medium | Supply disruption | Medium | Medium |
Rows ordered by severity; customer concentration (SEER) and AI-chip dependence are the most acute partner risks given geopolitical supply constraints.
[CR006, CR010, CR011, CR020]| Role / function | Dependency or gap | Likelihood | Severity | Mitigation | Diligence path |
|---|---|---|---|---|---|
| Founder / CEO (Lai Jie) | Key-person concentration | Low-medium | High | Not publicly evidenced | Assess retention/succession |
| Technical leadership | Thin public documentation | Medium | Medium | Unknown | Verify team credentials |
| Manufacturing execution | New at mass scale | Medium | High | Wuxi build-out | Review ops leadership |
| Commercial / GTM team | Channel-reliant | Medium | Medium | Partner channels | Assess direct sales capacity |
| Bench depth | Not publicly evidenced | Medium | Medium | Unknown | Review org chart |
Rows ordered by severity; founder key-person risk and unproven mass-manufacturing execution are the principal people/execution exposures, with limited public mitigation evidence.
[CR013, CR014, CR035]How technology, manufacturing, financing, and regulatory risks transmit into revenue, margin, and valuation.
[CR021, CR009, CR007, CR032]7.4 Mitigations, Kill Criteria, and Risk Verdict
Mitigations exist but are early-stage. Stardust's freshly raised equity, strategic backers, alignment with emerging standards, availability of liability insurance, and multi-scenario product diversification reduce some exposure, but none neutralizes the core technology and financial risks, so residual exposure remains material-to-critical across most categories. Investors should track a defined set of monitorable triggers and kill criteria: actuator field-failure rates, delivered units versus the Wuxi production plan, margin disclosure, financing runway and round progress, US legislation status, and customer-order diversification. The principal thesis-break events are evidence of systemic actuator failures, a failed Wuxi production ramp, or a financing-market freeze that leaves the company unable to fund scale-up; a US market-access ban would materially shrink the addressable market. The overall risk verdict is very high, driven by unproven technology reliability, financial opacity, and rising regulatory and geopolitical exposure. The remaining unresolved gap is the near-total absence of disclosed operating, reliability, and team data on which to base a more precise risk quantification.[CR022, CR026, CR027, CR028, CR029, CR036]
| Risk | Monitorable trigger | Threshold / event | Action implication |
|---|---|---|---|
| Actuator reliability | Field-failure rate | Systemic failures reported | Exit / halt - thesis break |
| Manufacturing ramp | Delivered units vs plan | Wuxi ramp misses targets | Reassess - execution failure |
| Unit economics | Margin disclosure | Persistently negative margins | De-risk - model failure |
| Financing | Runway / round progress | Failed raise or frozen market | Exit - capital risk |
| Regulatory / geopolitical | US legislation status | US ban enacted | Reassess TAM - access loss |
| Customer concentration | Order diversification | SEER order not delivered/repeated | Reassess traction |
Triggers are monitorable proxies for the top risks; systemic actuator failure, a failed Wuxi ramp, or a financing freeze are the primary thesis-break events.
[CR027, CR028, CR029, CR021]7.5 Exhibits
08Valuation
8.1 Recommendation and Investment Thesis
Our recommendation is track, with an overall score of 6.2 out of 10 at low-to-medium confidence. The logic runs from genuine early traction - thousand-unit-scale orders, multi-city deployments, and a commercially priced flagship - and a differentiated rope/cable-driven architecture, through a very high risk profile and thin financial disclosure, to a valuation we judge expensive relative to demonstrated fundamentals. The bull thesis is that rope-driven differentiation, combined with first-mover commercial pricing and policy-supported domestic demand, could translate into outsized share of a large future market. The anti-thesis is equally credible: the core actuator technology is unproven at scale, orders are concentrated bookings rather than delivered value, unit economics are undisclosed, competition from the Unitree-AgiBot duopoly is intense, and geopolitical restrictions could cap global expansion. Because both narratives are plausible and the disclosure needed to adjudicate them is absent, monitoring defined triggers is more prudent than committing capital now. Conditions that would upgrade the view to buy are disclosed positive unit economics and independently proven actuator reliability at scale.[CV014, CV015, CV016, CV024, CV025, CV030]
| Dimension | Assessment |
|---|---|
| Recommendation | Track |
| Overall score | 6.2 / 10 |
| Confidence | Low-medium |
| Risk rating | Very high |
| Valuation stance | Expensive |
| Current valuation | >RMB10B (~$1.38B) |
| Capital raised | ~$150M (>RMB1B Series B) |
Summary judgment; track reflects real traction offset by thin disclosure and very high risk.
[CV001, CV002, CV003, CV014, CV015, CV016]| Thesis (bull view) | Anti-thesis (bear view) |
|---|---|
| Rope-driven differentiation enables lighter, safer, cheaper humanoids | Unconventional actuators are unproven at scale; reliability unknown |
| Early thousand-unit orders signal real commercial demand | Orders are concentrated, bookings not deliveries, ROI unproven |
| Large future TAM (~$38B by 2035) with China output dominance | Bubble/overcapacity warnings imply multiple compression |
| Strategic backers (Thundersoft) and standards alignment | Thin financial disclosure; unit economics undisclosed |
| First-mover, commercially priced T1 (RMB89,900) | Aggressive price may mean thin/negative margins |
| Policy-supported domestic demand environment | Geopolitical limits (US restrictions) cap global expansion |
Balanced thesis/anti-thesis; each bull point has a credible bear counter.
[CV024, CV025, CV012, CV021]Evidence path from traction, differentiation, risk, disclosure, and valuation to the track verdict.
[CV014, CV036, CV012]Headline investment KPIs for Stardust Intelligence.
[CV001, CV002, CV014, CV015, CV016]8.2 Valuation, Scenarios, and Sensitivity
Stardust reached a valuation exceeding RMB10 billion (~$1.38B) in mid-2026, having raised over RMB1 billion across three consecutive Series B rounds in roughly three months, with cumulative capital of approximately $150M and China Renaissance advising. Crucially, no public revenue, ARR, or margin figures exist, so no fundamentals-based multiple can be computed; the mark reflects frontier-leader optionality rather than demonstrated economics. Valuation sensitivity is dominated by assumed unit volume, gross margin, and terminal market share, with TAM-realization timing a secondary factor given the opportunity is large but distant. Across scenarios the outcome range is wide: the bull case assumes a successful Wuxi scale-up, proven actuator reliability, and multi-sector order conversion, yielding a high return multiple; the base case assumes gradual commercialization and modest share in a growing but competitive China market for a moderate outcome; and the bear case - actuator or manufacturing failure, a financing freeze, or duopoly displacement - implies substantial impairment. Sector bubble and overcapacity warnings add multiple-compression risk if humanoid enthusiasm cools, reinforcing the expensive stance. This data is current to mid-2026.[CV001, CV002, CV003, CV013, CV017, CV018]
| Scenario | Key assumptions | Outcome | Implied return |
|---|---|---|---|
| Bull | Wuxi scales, actuators proven, multi-sector orders convert | Frontier leader; large share of growing TAM | High multiple |
| Base | Gradual commercialization, modest China share, competitive market | Viable niche player; moderate growth | Moderate |
| Bear | Actuator/mfg failure, financing freeze, duopoly displacement | Impairment or down-round | Substantial loss |
Scenario outcomes span a very wide range, reflecting early-stage uncertainty.
[CV017, CV018, CV019, CV020]Approximate relative sensitivity of valuation to key assumptions.
Weights are qualitative diligence estimates, not a fitted model.
[CV029, CV010, CV011]Illustrative multiple-of-invested-capital range by scenario.
Ranges are scenario illustrations, not forecasts.
[CV020, CV017, CV018, CV019]8.3 Comparable Valuations and Market Context
Comparable humanoid valuations frame both the opportunity and the froth. In China, Unitree is pursuing an IPO at roughly $7B and Galbot has reached about $3B, while UBTech offers a public-market reality check whose exchange valuation typically sits well below the multiples implied by hot private rounds. In the US, Figure AI (~$39B) and Apptronik (~$5.5B) show how far private marks can run in a different capital-market and hype environment. Against these, Stardust's ~$1.38B mark sits below the leaders, consistent with its earlier commercialization stage. On the market side, Goldman Sachs projects a global humanoid TAM of roughly $38B by 2035, and China accounts for the overwhelming majority of global humanoid output, underpinning a credible domestic base-case growth path; more speculative trillion-dollar narratives exist but are distant and should not anchor near-term value. Additional domestic entrants - AgiBot and Fourier among them - broaden the comparable set and intensify competition for the same capital and customers, pressuring relative valuation. Analysts also caution that Chinese output is outpacing demonstrated demand, a risk to the growth assumptions embedded in any bullish comparable read-across.[CV005, CV006, CV007, CV008, CV009, CV010]
| Company | Region | Stage | Valuation | Basis | Read-across to Stardust |
|---|---|---|---|---|---|
| Unitree | China | Pre-IPO | ~$7B | IPO reports | China leader; higher mark |
| Figure AI | US | Private | ~$39B | VC round reports | Extreme US private pricing |
| Apptronik | US | Private | ~$5.5B | VC round reports | Leading US comparable |
| Galbot | China | Private | ~$3B | VC round reports | Close domestic comparable |
| UBTech | China | Listed | Public market cap | Exchange listing | Public-market reality check |
Comparable valuations from IPO/VC/exchange sources; Stardust (~$1.38B) sits below peers, reflecting earlier stage.
[CV005, CV006, CV007, CV008, CV009, CV037]8.4 Thesis-Break Triggers and Diligence Asks
Because the investment case hinges on facts not yet disclosed, we translate the risks into monitorable triggers and gating diligence asks. The primary thesis-break triggers are evidence of systemic actuator failure, a failed Wuxi production ramp, persistent negative margins once financials are disclosed, or a financing-market freeze; competitive displacement by the duopoly and an enacted US ban are secondary triggers that would force a TAM reassessment. The investment KPIs to track are delivered units, gross margin, order-backlog conversion, financing runway, and field-failure rate. Before an investment decision, the gating diligence asks are audited financials, unit economics by product, actuator reliability and MTBF data, order-to-delivery conversion evidence, and cap-table and round terms, with a team and org-chart review to assess execution depth. Clearing the financial and reliability asks with positive results would justify upgrading from track to buy; failing them, or hitting any thesis-break trigger, would argue for standing down. The key unresolved gap is that essentially all fundamental valuation inputs - revenue, margins, and reliability data - remain undisclosed, capping the precision of any valuation view.[CV026, CV027, CV028, CV030, CV031, CV023]
| Trigger | Signal | Threshold / event | Recommendation impact |
|---|---|---|---|
| Actuator reliability | Field-failure data | Systemic failures | Exit - thesis break |
| Manufacturing ramp | Delivered vs plan | Failed Wuxi ramp | Downgrade |
| Unit economics | Margin disclosure | Persistent negative margins | Downgrade |
| Financing | Round progress | Frozen market / failed raise | Exit |
| Competition | Share metrics | Duopoly displacement | Downgrade |
| Regulatory | US legislation | Ban enacted | Reassess TAM |
Monitorable triggers mapped to recommendation impact; systemic actuator failure and financing freeze are the primary thesis-break events.
[CV026, CV027, CV031]| Ask | Purpose | Priority |
|---|---|---|
| Audited financials | Establish revenue/margin base | High |
| Unit economics by product | Validate pricing viability | High |
| Actuator reliability / MTBF data | De-risk core technology | High |
| Cap table and round terms | Assess dilution/liquidation | Medium |
| Order-to-delivery conversion | Verify traction quality | High |
| Team / org chart | Assess execution depth | Medium |
Diligence asks ordered by decision-impact; financials, unit economics, and actuator reliability are gating.
[CV028, CV030, CV036]8.5 Exhibits
Disclaimer
This report is a public-evidence diligence snapshot, not investment advice. Important financial, legal, technical, and contractual facts remain non-public and should be verified directly with management and primary documents before any investment decision.
Evidence index
| ID | Statement | Confidence | Sources |
|---|---|---|---|
| CO001 | Stardust Intelligence (Astribot) was founded in Shenzhen in December 2022. | High | SO001, SO002, SO003 |
| CO002 | The company is headquartered in Shenzhen (Nanshan district), China. | High | SO001, SO002 |
| CO003 | The company operates under the Astribot brand (Chinese name 星尘智能, Xingchen Zhineng). | Medium | SO001, SO004 |
| CO004 | Founder and CEO Lai Jie was the first engineer at Tencent Robotics X and previously led Baidu's Xiaodu robot team. | Medium | SO005, SO004 |
| CO005 | The core founding team was drawn largely from Tencent Robotics X. | Medium | SO005, SO004 |
| CO006 | The company pioneered a software-hardware integrated 'Design for AI' (DFAI) full-stack architecture coupling AI models, an embodied OS, and a rope-driven body. | Medium | SO001, SO006 |
| CO007 | Stardust Intelligence is at Series B stage and reached unicorn status in mid-2026. | Medium | SO007, SO003 |
| CO008 | The company's valuation surpassed RMB10 billion (~$1.38 billion) in mid-2026. | Medium | SO007, SO008, SO003 |
| CO009 | The Series B totaled more than RMB1 billion, raised across three consecutive rounds within roughly three months. | Medium | SO009, SO010, SO011 |
| CO010 | China Renaissance (华兴资本) served as the sole financial advisor for the Series B. | Medium | SO010 |
| CO011 | Disclosed Series B investors include the Liangxi fund, Yangzhou Longtou core-chip fund, Zhongbo Juli, Thundersoft, and Kede Education. | Medium | SO012, SO013 |
| CO012 | Thundersoft made a strategic investment and is pursuing thousand-unit commercial cooperation with Stardust Intelligence. | Medium | SO013, SO012 |
| CO013 | Earlier financing included an angel round led by Yunqi Partners, a Pre-A led by Matrix Partners China, and an A round with Jinqiu Capital and Ant Group. | Medium | SO014, SO004 |
| CO014 | Third-party trackers estimate lifetime capital raised in the range of roughly $150 million. | Low | SO014 |
| CO015 | The T1 rope-driven humanoid launched in May 2026 priced from RMB89,900. | Medium | SO015, SO016 |
| CO016 | The S1 dual-arm robot debuted at the World Robot Conference in August 2024 and drew global attention for its speed and dexterity. | Medium | SO017, SO006 |
| CO017 | Rope/cable-driven (tendon) actuation is the company's core mechanical differentiator versus conventional motor-driven joints. | Medium | SO001, SO016 |
| CO018 | The company reports thousand-unit orders spanning industrial, retail/commercial, and research/education sectors. | Medium | SO018, SO019 |
| CO019 | In September 2025 SEER (Xiangong Intelligence) signed a thousand-unit industrial humanoid order, described as China's first at that scale. | Medium | SO019, SO018 |
| CO020 | The company frames itself around 'Physical AI' commercialization for the embodied-intelligence era. | Medium | SO011 |
| CO021 | Reported commercial deployments span multiple Chinese cities across retail, tourism, research, and industrial settings. | Low | SO009, SO011 |
| CO022 | At CHTF in November 2025 the company signed an embodied-AI order and dev-platform partnership with Baidu and Jishu Diedai. | Medium | SO020 |
| CO023 | Revenue, ARR, gross margin, and headcount are not publicly disclosed. | Medium | SO001 |
| CO024 | The company operates in an intensely competitive Chinese humanoid market led by volume players Unitree and AgiBot. | Medium | SO021, SO022 |
| CO025 | Analysts and Chinese officials have flagged bubble and overvaluation risk across the humanoid-robot sector. | Medium | SO023 |
| CO026 | The company's ~RMB10B valuation places it among a cohort of Chinese humanoid unicorns formed in 2025-2026. | Medium | SO024, SO003 |
| CO027 | The legal entity is Astribot (Shenzhen) Co., Ltd., with Chinese ICP registration 粤ICP备2025360189号. | Medium | SO001, SO002 |
| CO028 | T1 targets five scenario families: home service, commercial stores, research/education, tourism, and light industry. | Medium | SO016, SO015 |
| CO029 | Early S1 research units were positioned as premium, with third-party price estimates around $100,000-$150,000. | Low | SO006 |
| CO030 | Founder Lai Jie is reported to have roughly 16 years of robotics experience and a master's from Wuyi University. | Low | SO005 |
| CO031 | Public sources concentrate the company's narrative on founder-CEO Lai Jie, creating key-person dependence. | Medium | SO005, SO004 |
| CO032 | Dai Yuan (戴媛) is identified as a co-founder of the company. | Low | SO004 |
| CO033 | The vision stated by the company is to bring versatile AI robots into billions of people's lives and to promote human-robot co-existence. | Medium | SO001 |
| CO034 | Milestone chronology spans a 2023 angel round, the 2024 S1 debut, 2024-2025 Pre-A/A rounds, the May 2026 T1 launch, and the mid-2026 Series B. | Medium | SO014, SO003, SO007 |
| CO035 | No public board roster, control rights, or ownership percentages have been disclosed. | Low | SO009 |
| CO036 | The Series B propelled Shenzhen's embodied-AI cluster, adding another RMB10B-valued company. | Medium | SO008, SO025 |
| CO037 | Independent robotics trackers profile Astribot as a leading tendon-driven humanoid maker. | Low | SO006, SO004 |
| CM001 | China accounted for roughly 90% of global humanoid-robot output in 2025. | High | SM001, SM002 |
| CM002 | China's humanoid-robot output is forecast to surge about 94% in 2026, led by Unitree and AgiBot. | High | SM001, SM003 |
| CM003 | EmbodiedGlobal projects China's 2026 humanoid market at roughly RMB104.7 billion, with some sources citing figures up to RMB1,047 billion. | Medium | SM002, SM004 |
| CM004 | Published China humanoid market estimates for 2026 diverge widely by methodology, from tens of billions to over one trillion RMB. | Medium | SM004, SM005, SM006 |
| CM005 | The China humanoid market is projected to grow at a CAGR exceeding 65% over the forecast horizon. | Medium | SM002, SM005 |
| CM006 | Global humanoid-robot sector revenue in 2026 is estimated at roughly $6.24 billion. | Medium | SM007, SM008 |
| CM007 | Goldman Sachs projects a global humanoid TAM around $38 billion by 2035. | Medium | SM007 |
| CM008 | Morgan Stanley forecasts roughly 50,000 humanoid-robot sales in China for 2026. | Medium | SM009 |
| CM009 | Embodied-AI financing in China reached over RMB33.5 billion in the first eleven months of 2025, about four times the prior year. | Medium | SM005 |
| CM010 | China's 2026 robotics sector has seen over 500 financing rounds worth roughly RMB96 billion, with tech giants and carmakers entering. | Medium | SM010, SM011 |
| CM011 | The addressable market for Stardust is enterprise service and light-industrial humanoids in China, excluding quadrupeds and fixed automation. | Medium | SM012, SM013 |
| CM012 | Status-quo substitutes include human labor, fixed industrial automation, collaborative arms (cobots), and quadruped robots. | Medium | SM013, SM014 |
| CM013 | Buyers span industrial/manufacturing, logistics, retail/commercial, tourism/hospitality, research, and education segments. | Medium | SM015, SM011 |
| CM014 | MIIT and SASAC launched a 2026 nationwide initiative to deploy humanoid robots across industrial and service scenarios at scale. | Medium | SM016 |
| CM015 | China released the world-first national standard system (HEIS 2026) for humanoid robots and embodied AI to support scale-up. | Medium | SM017, SM018 |
| CM016 | Government and municipal programs (e.g., Shenzhen, Wuxi/Liangxi) provide procurement demand and scenario funding. | Medium | SM016, SM019 |
| CM017 | Cost declines - exemplified by sub-RMB90,000 humanoids - are a primary demand driver lowering the adoption barrier. | Medium | SM015, SM020 |
| CM018 | Near-term ROI is uncertain: many deployed robots operate at only 20-30% of human efficiency in trials. | Medium | SM021 |
| CM019 | Analysts warn the sector runs ahead of real commercial traction, flagging bubble and overcapacity risk. | Medium | SM009, SM022 |
| CM020 | Reliability, dexterity, battery, and safety limitations constrain industrial deployment beyond pilots. | Medium | SM021, SM020 |
| CM021 | The enterprise adoption path runs from demo to pilot to limited production to scaled deployment, gated by ROI proof. | Medium | SM021, SM011 |
| CM022 | Education-sector procurement is driven by vocational schools and universities, often with state or institutional budgets. | Medium | SM015, SM016 |
| CM023 | Tech giants (Alibaba, ByteDance) and carmakers (BYD, XPeng) are entering humanoid robotics, intensifying competition and demand signals. | Medium | SM023, SM010 |
| CM024 | China is projected to account for roughly 85% of global humanoid shipments in 2026. | Medium | SM001, SM024 |
| CM025 | Serviceable obtainable market for Stardust is a small early slice of Chinese enterprise humanoid demand, measured in thousands of units near-term. | Low | SM025, SM007 |
| CM026 | Public showcases such as InnoEx 2026 and CHTF signal rising buyer and consumer interest in humanoids. | Low | SM026, SM027 |
| CM027 | The 2026 estimates are current as of the run date but derive from divergent third-party methodologies rather than audited data. | Medium | SM004, SM007 |
| CM028 | Morgan Stanley and other banks caution the humanoid boom is further from mass commercialization than market enthusiasm implies. | Medium | SM009 |
| CM029 | National standards reduce fragmentation and improve safety, but industry-wide adoption of the standards will take time. | Medium | SM028, SM029 |
| CM030 | The value chain spans actuator/sensor/chip suppliers, body integrators, AI-model developers, and deployment/service partners. | Medium | SM014, SM030 |
| CM031 | Switching costs for enterprise buyers include integration, retraining, and safety-certification effort per deployment. | Medium | SM021, SM017 |
| CM032 | Semiconductor import restrictions constrain Chinese robots' AI-software and compute progress. | Medium | SM021 |
| CM033 | Humanoid robotics attracted over $5 billion of cumulative industry investment globally since 2020. | Medium | SM012, SM007 |
| CM034 | China's humanoid market is widely described as entering its 'mass production year' in 2026. | Medium | SM004, SM011 |
| CM035 | Long-run analyst forecasts (e.g., Morgan Stanley) envision multi-million-unit and trillion-dollar-scale humanoid markets by mid-century. | Low | SM009, SM007 |
| CM036 | Company positioning targets the 'Physical AI' commercialization segment within embodied intelligence. | Medium | SM031 |
| CP001 | Unitree and AgiBot together hold roughly 80% of China's humanoid-robot market. | High | SP001, SP002 |
| CP002 | Unitree is targeting an IPO reportedly valuing the company near $7 billion, far above Stardust's ~$1.38B valuation. | High | SP003, SP004 |
| CP003 | Unitree's G1 humanoid retails around $16,000, competing directly with Stardust's affordable positioning. | Medium | SP003, SP005 |
| CP004 | AgiBot (Zhiyuan Robotics) is a leading Chinese humanoid maker pursuing mass production with strong state and investor backing. | Medium | SP001, SP006 |
| CP005 | Fourier Intelligence, a rehabilitation-robotics pioneer, fields the GR-series humanoids targeting research and healthcare. | Medium | SP007, SP008 |
| CP006 | Galbot reached a valuation around $3 billion, exceeding Stardust's, positioning it as a well-funded China peer. | Medium | SP009, SP010 |
| CP007 | UBTech is a publicly listed Chinese humanoid maker with its Walker series targeting industrial and service deployments. | Medium | SP005, SP006 |
| CP008 | US rival Figure AI has been valued around $39 billion, dwarfing all Chinese humanoid startups on paper. | Medium | SP011, SP005 |
| CP009 | 1X Technologies' Neo humanoid is priced near $20,000 for Western consumer/enterprise markets. | Medium | SP005, SP011 |
| CP010 | Apptronik, maker of Apollo, has been valued around $5.5 billion with major industrial partnerships. | Low | SP011, SP005 |
| CP011 | Tesla's Optimus is a high-profile entrant leveraging Tesla's manufacturing and AI scale. | Low | SP005, SP011 |
| CP012 | Stardust's core differentiation is rope/tendon-driven actuation enabling lightweight, compliant, high-speed manipulation. | Medium | SP012, SP013 |
| CP013 | Stardust's S1 demonstrated end-effector speeds up to ~10 m/s and ~0.1 mm repeatability, among the fastest shown publicly. | Medium | SP014, SP015, SP016, SP017 |
| CP014 | Stardust pursues a 'Design-for-AI' full-stack strategy combining an AI model, embodied OS, and rope-driven body. | Medium | SP012, SP013 |
| CP015 | Stardust's T1 at RMB89,900 undercuts many humanoid rivals, positioning on affordability. | Medium | SP018, SP019 |
| CP016 | Most humanoid competitors use conventional motor-driven or harmonic-drive joints rather than tendon actuation. | Medium | SP007, SP005 |
| CP017 | Key enterprise buying criteria are payload/dexterity, autonomy, price, reliability, and deployment support. | Medium | SP006, SP020 |
| CP018 | Switching costs are moderate: integration, safety certification, and retraining create some lock-in but buyers can multi-home across vendors. | Medium | SP020, SP021 |
| CP019 | Stardust trails Unitree and AgiBot on scale, funding, and mass-production maturity. | Medium | SP003, SP001 |
| CP020 | Tech giants (Alibaba, ByteDance) and carmakers (BYD, XPeng) are likely entrants intensifying competition. | Medium | SP022, SP023 |
| CP021 | China's humanoid firms benefit from a dense domestic supply chain, aiding cost competitiveness across all players. | Medium | SP006, SP024 |
| CP022 | Stardust's moat rests on actuator know-how and full-stack integration, both replicable by better-funded rivals over time. | Medium | SP012, SP013 |
| CP023 | Commoditization risk is high as sub-RMB100k humanoids proliferate and standards reduce differentiation. | Medium | SP025, SP019 |
| CP024 | Unitree's brand recognition and viral demos give it distribution and mindshare advantages Stardust lacks. | Medium | SP003, SP026 |
| CP025 | Stardust's S1 gained global attention after its WRC 2024 debut, building brand among researchers. | Medium | SP027, SP013, SP028 |
| CP026 | Competitive intelligence here is current to mid-2026 but valuations and share shift rapidly. | Medium | SP003, SP002 |
| CP027 | AgiBot and Unitree are furthest along in scaled production and government-backed deployments. | Medium | SP001, SP006 |
| CP028 | Fourier targets rehabilitation and research niches, a different beachhead than Stardust's general-purpose commercial push. | Low | SP007, SP008 |
| CP029 | Ecosystem lock-in could emerge if Stardust's DuoCore OS and developer platform attract third-party applications. | Low | SP012, SP029 |
| CP030 | Internal build and continued human labor remain default alternatives for cost-sensitive buyers. | Medium | SP020, SP030 |
| CP031 | Chinese humanoids increasingly compete on price, with several models now below RMB100,000. | Medium | SP019, SP005 |
| CP032 | Stardust's dexterity and speed leadership is demo-stage; peers dispute real-world reliability claims across the sector. | Medium | SP020, SP013 |
| CP033 | US players hold valuation and capital leads but face China's manufacturing-cost and speed advantages. | Low | SP011, SP024 |
| CP034 | EngineAI and other emerging Chinese startups add to a crowded field of 50+ humanoid developers. | Medium | SP005, SP031 |
| CP035 | Stardust's affordability plus full-stack approach is a genuine but narrow wedge against larger incumbents. | Medium | SP018, SP012 |
| CP036 | Feature parity across humanoids is converging as suppliers share actuators, sensors, and AI toolkits. | Low | SP006, SP031 |
| CI001 | Stardust Intelligence raised more than RMB1 billion across three consecutive Series B rounds in mid-2026, reaching a valuation above RMB10 billion (~$1.38B). | High | SI001, SI002, SI003 |
| CI002 | Stardust's T1 humanoid is priced at RMB89,900 (~$12,500), launched in May 2026. | High | SI004, SI005, SI002 |
| CI003 | Stardust's estimated lifetime funding is around $150 million across angel, Pre-A, A, and Series B rounds. | Medium | SI006, SI007 |
| CI004 | Primary revenue streams are hardware sales of humanoid robots (T1, S1) to enterprise, research, and education buyers. | Medium | SI002, SI005 |
| CI005 | The S1 research/dual-arm system is estimated to sell in the ~$100,000-150,000 range for research customers. | Low | SI008, SI009 |
| CI006 | Stardust has not disclosed revenue, gross margin, burn, or runway; it is a private company with undisclosed financials. | Medium | SI010, SI006 |
| CI007 | Series B proceeds are earmarked for mass production, R&D, and commercialization/go-to-market scale-up. | Medium | SI002, SI011 |
| CI008 | Stardust's investor syndicate includes Thundersoft, Kede Education, Liangxi Fund, a Yangzhou core-chip fund, and Zhongbo Juli, with China Renaissance as sole advisor. | Medium | SI012, SI003 |
| CI009 | Stardust received a first-of-its-kind thousand-unit industrial humanoid order from SEER (Xiangong) in September 2025. | Medium | SI013, SI014 |
| CI010 | Additional orders and a developer-platform MOU were secured at CHTF in November 2025. | Medium | SI015, SI016 |
| CI011 | Stardust is building mass-production capacity at a Wuxi (Liangxi) facility, implying meaningful manufacturing capex. | Medium | SI011, SI002 |
| CI012 | The sub-RMB90,000 T1 price raises questions about gross-margin sustainability given humanoid bill-of-materials costs. | Medium | SI017, SI018 |
| CI013 | Humanoid hardware manufacturing imposes significant working-capital and inventory demands during scale-up. | Medium | SI019, SI018 |
| CI014 | Enterprise humanoid sales cycles are long, involving pilots, integration, and safety validation before production orders. | Medium | SI020, SI021 |
| CI015 | Revenue recognition on large multi-unit orders carries timing risk tied to delivery, acceptance, and deployment milestones. | Medium | SI013, SI021 |
| CI016 | Deployed robots require ongoing service, maintenance, and support, adding to cost of delivery. | Medium | SI021, SI020 |
| CI017 | Sector-wide financing-bubble and overcapacity warnings could tighten Stardust's access to future capital. | Medium | SI022, SI023 |
| CI018 | Listed comparable UBTech's public financials show humanoid makers face heavy losses despite high valuations. | Medium | SI024, SI025 |
| CI019 | Stardust's capital raised trails better-funded rivals such as Unitree (~$7B IPO target) and Figure AI (~$39B). | Medium | SI026, SI027 |
| CI020 | China's embodied-AI financing surged past RMB33.5B in the first eleven months of 2025, easing near-term capital access. | Medium | SI028 |
| CI021 | No public evidence indicates material debt or project-finance obligations; capital appears equity-funded. | Low | SI006, SI002 |
| CI022 | The next-round trigger is likely tied to hitting mass-production and revenue milestones from the Wuxi facility. | Low | SI011, SI002 |
| CI023 | Financing facts are current to mid-2026 (Series B closed ~June 2026), the most recent available as of the run date. | Medium | SI001, SI029 |
| CI024 | Stardust is deployed across roughly six Chinese cities, a public operational-scale signal absent revenue disclosure. | Low | SI005, SI030 |
| CI025 | Revenue mix is inferred to skew toward hardware today, with education and developer-platform revenue nascent. | Low | SI005, SI015 |
| CI026 | Estimated near-term revenue and burn cannot be reliably bounded from public data; ranges are speculative. | Low | SI006, SI031 |
| CI027 | Cost declines across the China supply chain support Stardust's ability to price aggressively while pursuing scale. | Medium | SI019, SI018 |
| CI028 | Government and municipal programs (Wuxi/Liangxi, Shenzhen) may offset capex through subsidies or scenario funding. | Low | SI032, SI011 |
| CI029 | The rapid three-round Series B in ~three months signals strong investor demand but also aggressive capital consumption plans. | Medium | SI001, SI033 |
| CI030 | Financial verdict: capital-rich but revenue-opaque; the investment case rests on unproven unit economics and manufacturing execution. | Medium | SI006, SI021 |
| CI031 | CAC/payback proxies are unavailable; enterprise deal economics must be obtained directly in diligence. | Low | SI020, SI021 |
| CI032 | Public financial gaps are extensive: revenue, margin, burn, runway, and customer-level economics are all undisclosed. | Medium | SI010, SI006 |
| CI033 | Thundersoft's strategic investment may provide in-kind manufacturing, OS, and supply-chain support beyond cash. | Low | SI034, SI002 |
| CI034 | Humanoid unit economics are widely reported as unproven sector-wide, with ROI dependent on effective output. | Medium | SI021, SI020 |
| CI035 | Stardust's valuation-to-revenue relationship is unmeasurable without revenue disclosure, a key diligence blocker. | Medium | SI006, SI031 |
| CI036 | Global humanoid supply-chain constraints could raise component costs and pressure margins during scale-up. | Medium | SI019 |
| CE001 | The T1 humanoid launched in May 2026 at RMB89,900 with 23 degrees of freedom, standing ~1.53-1.55m and weighing ~66kg. | High | SE001, SE002, SE003 |
| CE002 | The S1 uses rope/cable-driven (tendon) actuation and demonstrated end-effector speeds up to ~10 m/s with ~0.1 mm repeatability. | High | SE004, SE002, SE005 |
| CE003 | Stardust follows a 'Design-for-AI' (DFAI) full-stack strategy combining an AI model, an embodied OS (DuoCore), and a rope-driven body. | Medium | SE002, SE006 |
| CE004 | Rope/cable-driven actuation relocates motors to the torso and transmits force via cables, yielding lighter, faster, more compliant limbs. | Medium | SE004, SE007 |
| CE005 | The S1 is a dual-arm wheeled system with 7-DoF arms and ~5 kg payload per arm, aimed at manipulation research and service tasks. | Medium | SE004, SE008 |
| CE006 | The S1 debuted at the World Robot Conference in August 2024, drawing global attention for its speed and dexterity. | Medium | SE009, SE006 |
| CE007 | The T1 supports multiple deployment scenarios including home, commercial, research/education, tourism, and light industry. | Medium | SE010, SE002 |
| CE008 | Stardust maintains a public GitHub organization providing developer-facing repositories and tools. | Medium | SE011 |
| CE009 | The embodied-intelligence layer integrates perception, planning, and manipulation for autonomous task execution. | Medium | SE002, SE006 |
| CE010 | Rope-driven actuation is an unconventional approach; most humanoid competitors use motor or harmonic-drive joints. | Medium | SE012, SE013 |
| CE011 | Long-term reliability and maintenance of rope/cable actuators under sustained commercial load are not independently validated. | Medium | SE014, SE015 |
| CE012 | Stardust plans mass production of the T1 at a Wuxi (Liangxi) facility, targeting scale-up in 2026. | Medium | SE016, SE017 |
| CE013 | The product roadmap runs from S1 (2024 research debut) to T1 mass-market launch (May 2026) to production scale-up (2026). | Medium | SE009, SE017 |
| CE014 | China's HEIS 2026 national standards for humanoid robots and embodied AI set safety and interoperability requirements applicable to Stardust. | Medium | SE018, SE019 |
| CE015 | Shenzhen introduced embodied-AI liability insurance in 2026, part of an emerging safety and compliance framework for humanoid deployment. | Medium | SE020 |
| CE016 | Compliant, lower-inertia limbs from rope actuation can improve human-robot interaction safety versus rigid high-torque joints. | Low | SE004, SE007 |
| CE017 | Critical dependencies include actuator components, sensors, AI compute/chips, and the domestic robotics supply chain. | Medium | SE021, SE022 |
| CE018 | Semiconductor and AI-compute access is a dependency risk given export restrictions affecting Chinese robotics. | Medium | SE015, SE022 |
| CE019 | T1 offers ~5 kg per-arm payload and 23 DoF, positioning it for light manipulation rather than heavy industrial loads. | Medium | SE001, SE010 |
| CE020 | Product maturity is highest for the demonstrated S1 platform and earlier-stage for T1 at-scale reliability. | Medium | SE004, SE017 |
| CE021 | Stardust's dexterity and speed leadership is validated in demos but not in independent, standardized benchmarks. | Medium | SE006, SE014 |
| CE022 | Deployment requires integration, safety validation, operator training, and ongoing maintenance per site. | Medium | SE015, SE014 |
| CE023 | The DuoCore embodied OS is positioned as a platform for third-party application development. | Low | SE002, SE023 |
| CE024 | Product/technology information is current to mid-2026, reflecting the T1 launch and Series B disclosures. | Medium | SE024, SE002 |
| CE025 | IP and know-how center on actuator design and full-stack integration; patent breadth is not publicly detailed. | Low | SE002, SE006 |
| CE026 | The T1's affordable price is enabled by design simplification and China's dense component supply chain. | Medium | SE024, SE021 |
| CE027 | Manipulation performance (speed, precision) is the product's headline technical claim and demo differentiator. | Medium | SE005, SE004 |
| CE028 | T1 targets both consumer/commercial and research/education buyers, broadening the addressable use base. | Medium | SE010, SE002 |
| CE029 | Safety controls must address collision avoidance, force limiting, and compliance with emerging standards. | Medium | SE018, SE020 |
| CE030 | Reliability of complex tendon routing and cable wear is a recognized engineering challenge for rope-driven designs. | Medium | SE007, SE014 |
| CE031 | The AI model layer (embodied intelligence) is central to autonomy but its benchmarked capability is undisclosed. | Low | SE002, SE022 |
| CE032 | Stardust competes technically with Unitree's G1 and Fourier's GR-series on capability and price. | Low | SE013, SE025 |
| CE033 | Developer signals (GitHub repositories) indicate an intent to build an application ecosystem around the platform. | Low | SE011, SE002 |
| CE034 | Quality and compliance evidence is thin publicly; certifications and MTBF data are not disclosed. | Medium | SE020, SE018 |
| CE035 | T1's 23-DoF, ~66kg full-humanoid form is more complex to manufacture reliably than S1's wheeled dual-arm base. | Low | SE001, SE004 |
| CE036 | Product/tech verdict: genuine, demonstrated dexterity leadership offset by unproven at-scale reliability and thin compliance disclosure. | Medium | SE004, SE014 |
| CU001 | Stardust is deployed across roughly six Chinese cities, spanning industrial, retail/commercial, and education settings. | High | SU001, SU002, SU003 |
| CU002 | The T1 launched in May 2026 at RMB89,900, targeting retail, industrial, and education buyers. | High | SU004, SU001, SU005 |
| CU003 | SEER (Xiangong) placed a first-of-its-kind thousand-unit industrial humanoid order with Stardust in September 2025. | Medium | SU006, SU007, SU008, SU009 |
| CU004 | The SEER order is reported as China's first thousand-unit-scale humanoid procurement, a landmark industrial demand signal. | Medium | SU007, SU010 |
| CU005 | At CHTF in November 2025, Stardust secured additional orders and a developer-platform MOU involving Baidu and Jishu Diedai. | Medium | SU011, SU012 |
| CU006 | Kede Education, a strategic investor, provides an education-sector distribution channel for Stardust's robots. | Medium | SU013, SU014 |
| CU007 | Reported thousand-unit purchase orders span retail, industrial, and education sectors. | Medium | SU001, SU006 |
| CU008 | Named production deployments and specific end-user identities behind the order signals are largely undisclosed. | Medium | SU007, SU015 |
| CU009 | No public retention, repeat-purchase, churn, or satisfaction (NRR/GRR/NPS) metrics are available. | Medium | SU015, SU016 |
| CU010 | Sector analysts caution that humanoid orders often outrun proven, sustained commercial ROI. | Medium | SU017, SU016 |
| CU011 | Customer concentration is a risk: a small number of large orders (e.g., SEER) dominate visible demand. | Medium | SU006, SU007 |
| CU012 | Education-sector procurement typically draws on institutional or state budgets, aiding pipeline stability. | Medium | SU013, SU018 |
| CU013 | Government and municipal programs (Wuxi/Liangxi, Shenzhen) support the customer pipeline via scenario funding. | Medium | SU019, SU018, SU020 |
| CU014 | The customer journey runs from showcase discovery to pilot to multi-unit order to multi-site expansion. | Medium | SU011, SU015 |
| CU015 | Public showcases (WRC, CHTF, InnoEx, Tokyo Humanoids Summit) are key customer-discovery surfaces. | Medium | SU021, SU011, SU022 |
| CU016 | The developer-platform MOU signals a partner/channel strategy to expand reach beyond direct sales. | Low | SU011, SU012 |
| CU017 | Reference quality of named proofs is moderate: orders are press-reported but lack independent deployment outcomes. | Medium | SU007, SU015 |
| CU018 | Customer evidence is current to late-2025/mid-2026, the freshest available as of the run date. | Medium | SU011, SU004 |
| CU019 | Industrial buyers (via SEER) represent the most concrete, largest-scale demand to date. | Medium | SU006, SU007 |
| CU020 | Retail/commercial deployments are reported at the scenario level but with limited named-account detail. | Low | SU001, SU002 |
| CU021 | Repeat and expansion orders beyond the initial announcements are not yet publicly documented. | Low | SU015, SU007 |
| CU022 | Land-and-expand potential exists if pilots convert to multi-site production, but conversion evidence is pending. | Low | SU015, SU011 |
| CU023 | Adoption-funnel conversion from showcase interest to production is the key unproven step. | Medium | SU015, SU016 |
| CU024 | Deployment across six cities suggests operational breadth but not necessarily deep per-site utilization. | Low | SU001, SU003 |
| CU025 | Order headlines (thousand units) should be treated as bookings signals pending delivery and acceptance. | Medium | SU006, SU015 |
| CU026 | China's humanoid deployment momentum broadly supports Stardust's customer-acquisition environment. | Medium | SU018, SU003, SU023, SU024 |
| CU027 | Customer outcomes (productivity, cost savings) from Stardust deployments are not publicly quantified. | Medium | SU015, SU007 |
| CU028 | Partner dependence on distributors (SEER) and education channels (Kede) concentrates go-to-market risk. | Medium | SU007, SU013 |
| CU029 | The education channel offers recurring institutional demand but modest per-unit revenue. | Low | SU013, SU001 |
| CU030 | Industrial deployment (SEER) targets material handling and repetitive tasks in manufacturing/logistics. | Medium | SU007, SU006 |
| CU031 | Customer verdict: strong early demand signals, weak evidence on production, retention, and outcomes. | Medium | SU007, SU015 |
| CU032 | Freshness risk is low for headline orders but outcome data may lag behind announcements. | Low | SU011, SU015 |
| CU033 | Buyer, user, and payer often differ (e.g., school procurement vs students vs state budget), affecting sales cycles. | Medium | SU013, SU018 |
| CU034 | Global attention from showcases builds a top-of-funnel that must still convert to paid production deployments. | Low | SU021, SU015 |
| CU035 | China's broader humanoid adoption (retail, industrial, education pilots) validates the target-segment demand. | Medium | SU018, SU002, SU025 |
| CU036 | Concentration in a few marquee orders makes early revenue lumpy and dependent on individual deals converting. | Medium | SU006, SU007 |
| CR001 | China released the world-first HEIS 2026 national standards system for humanoid robots and embodied AI, setting safety and interoperability requirements Stardust must meet. | High | SR001, SR002 |
| CR002 | US lawmakers introduced legislation (including a House Select Committee bill and the American Security Robotics Act) to ban or restrict government purchases of Chinese humanoid robots. | High | SR003, SR004 |
| CR003 | The proposed GUARD Act would extend the FCC covered-list framework to robotics, potentially restricting Chinese robots in the US market. | Medium | SR005, SR006 |
| CR004 | Rope/cable-driven actuator reliability at sustained commercial scale is unproven, the single most material technology risk. | Medium | SR007, SR008 |
| CR005 | Cable wear and complex tendon routing are recognized engineering challenges that could raise maintenance and failure rates. | Medium | SR007, SR008 |
| CR006 | Semiconductor and AI-compute export restrictions constrain Chinese robotics firms' software and compute progress. | Medium | SR009, SR010 |
| CR007 | Sector-wide humanoid financing-bubble and overcapacity warnings threaten future capital access. | Medium | SR011, SR012 |
| CR008 | Investors explicitly warn that humanoid robotics may be the next AI bubble, inflating valuations ahead of commercial reality. | Medium | SR013, SR008 |
| CR009 | Undisclosed revenue and margins against a sub-RMB90,000 price create high financial-model risk of thin or negative unit economics. | Medium | SR009, SR007 |
| CR010 | Customer concentration in a few marquee orders (notably SEER) makes early revenue lumpy and deal-dependent. | Medium | SR007, SR009 |
| CR011 | Go-to-market depends on partner channels (SEER distributor, Kede education), concentrating channel risk. | Low | SR007, SR008 |
| CR012 | Manufacturing scale-up at the Wuxi facility carries execution, yield, and working-capital risk. | Medium | SR014, SR010 |
| CR013 | Key-person risk attaches to founder Lai Jie, whose robotics vision and Tencent-derived credibility anchor the company. | Medium | SR015, SR016 |
| CR014 | Technical-team depth and credentials are thinly documented in English-language media, limiting external verification. | Low | SR015, SR017 |
| CR015 | China's Civil Code imposes product-liability exposure for defective robots causing harm, a legal risk for humanoid makers. | Medium | SR018, SR019 |
| CR016 | China's evolving AI governance (including a draft AI law) may impose future compliance obligations on embodied-AI firms. | Medium | SR018, SR001 |
| CR017 | Shenzhen's 2026 embodied-AI liability insurance signals rising regulatory attention to deployment safety and liability. | Medium | SR019, SR001 |
| CR018 | Human-robot-interaction safety risks (collision, force) require robust controls, especially in public/commercial settings. | Medium | SR019, SR007 |
| CR019 | Intense competition from the Unitree-AgiBot duopoly and new entrants poses displacement risk. | Medium | SR020, SR021 |
| CR020 | Dependency on strategic investor Thundersoft for manufacturing/OS support is a concentration and continuity risk. | Low | SR022, SR016 |
| CR021 | Risks transmit into the thesis via revenue (weak ROI), margin (aggressive pricing), financing (bubble), and valuation (multiple compression). | Medium | SR011, SR009 |
| CR022 | Residual exposure after early-stage mitigations remains material-to-critical across technology, financial, and regulatory categories. | Medium | SR008, SR007 |
| CR023 | US market-access restrictions could cap Stardust's international expansion and narrow its addressable market. | Medium | SR003, SR023 |
| CR024 | The risk assessment is current to mid-2026, reflecting the latest standards, legislation, and financing signals. | Medium | SR001, SR003 |
| CR025 | HEIS 2026 compliance will require certification effort and may raise costs during scale-up. | Medium | SR002, SR001 |
| CR026 | Mitigations include equity capital raised, strategic backers, standards alignment, and multi-scenario diversification. | Low | SR016, SR022 |
| CR027 | Monitorable triggers include delivered-unit conversion, margin disclosure, actuator field-failure rates, and financing runway. | Medium | SR007, SR008 |
| CR028 | A thesis-break trigger is evidence of systemic actuator failures or a failed Wuxi production ramp. | Medium | SR007, SR014 |
| CR029 | Another thesis-break trigger is a financing-market freeze that leaves Stardust unable to fund scale-up. | Medium | SR011, SR012 |
| CR030 | Geopolitical risk is rising: Chinese robots face growing scrutiny as strategic/security concerns in Western markets. | Medium | SR003, SR004 |
| CR031 | Regulatory standards are double-edged: they legitimize the sector but raise compliance costs for scaling firms. | Medium | SR002, SR024 |
| CR032 | Overcapacity in China's humanoid sector could trigger price wars, compressing Stardust's already-thin margins. | Medium | SR011, SR008 |
| CR033 | Operational reliance on a single flagship facility (Wuxi) concentrates manufacturing continuity risk. | Low | SR014, SR010 |
| CR034 | Standards fragmentation between China (HEIS) and international regimes could raise export-compliance friction. | Low | SR024, SR001 |
| CR035 | People-risk mitigation (deepening the leadership bench beyond the founder) is not publicly evidenced. | Low | SR015, SR017 |
| CR036 | Risk verdict: very high overall, driven by unproven technology reliability, financial opacity, and regulatory/geopolitical exposure. | Medium | SR008, SR003 |
| CR037 | Overcapacity and low-cost competition in China's humanoid sector could trigger price wars that compress Stardust's thin margins. | Medium | SR025, SR026 |
| CR038 | Analysts including Morgan Stanley caution that Chinese humanoid output is running ahead of demonstrated end-demand, raising demand-supply-gap risk. | Medium | SR027, SR028 |
| CR039 | Multiple Chinese standards and government bodies (MIIT, SAC/SESEC) govern humanoid safety and interoperability, defining Stardust's compliance surface. | Medium | SR029, SR030, SR031 |
| CR040 | Aggressive low-cost pricing across Chinese humanoid makers pressures unit economics and heightens Stardust's financial-model risk. | Medium | SR025, SR009 |
| CV001 | Stardust Intelligence reached a valuation of over RMB10 billion (~$1.38B) in mid-2026, achieving unicorn status. | Medium | SV001, SV002 |
| CV002 | Stardust raised over RMB1 billion across three consecutive Series B rounds (B, B+, B++) in about three months in 2026. | Medium | SV003, SV004 |
| CV003 | Stardust's cumulative capital raised is approximately $150M across its financing history. | Low | SV005, SV003 |
| CV004 | China Renaissance (Huaxing) advised the Series B financing, signaling institutional-grade deal structuring. | Medium | SV006, SV002 |
| CV005 | Unitree, the China humanoid leader, is pursuing an IPO at a reported valuation of roughly $7B. | High | SV007, SV008 |
| CV006 | US humanoid peer Figure AI has been valued at roughly $39B, illustrating extreme private-market pricing. | Medium | SV009, SV010 |
| CV007 | Apptronik has raised at a valuation of roughly $5.5B, a leading US humanoid comparable. | Medium | SV009, SV010 |
| CV008 | Chinese peer Galbot has reached a valuation of roughly $3B, a close domestic comparable. | Medium | SV011, SV009 |
| CV009 | UBTech is a publicly listed Chinese humanoid maker, providing a market-priced comparable reference. | Medium | SV012, SV013 |
| CV010 | Goldman Sachs projects a global humanoid TAM of roughly $38B by 2035, framing the long-run opportunity. | High | SV014, SV015 |
| CV011 | China accounts for the overwhelming majority (~90%+) of global humanoid output, supporting the domestic growth case. | Medium | SV016, SV017 |
| CV012 | Stardust's valuation implies frontier-leader pricing despite undisclosed revenue and unproven unit economics. | Medium | SV018, SV019 |
| CV013 | No public revenue, ARR, or margin figures exist to anchor a fundamentals-based valuation multiple. | Medium | SV005, SV018 |
| CV014 | The recommendation is track: real traction and differentiation are offset by thin disclosure and very high risk. | Medium | SV018, SV020 |
| CV015 | The diligence assigns an overall score of 6.2 with low-to-medium confidence. | Low | SV005, SV018 |
| CV016 | The valuation stance is expensive relative to demonstrated fundamentals but defensible on optionality. | Medium | SV021, SV018 |
| CV017 | A bull scenario assumes successful Wuxi scale-up, actuator reliability proven, and multi-sector order conversion. | Low | SV022, SV014 |
| CV018 | A base scenario assumes gradual commercialization with modest share in a growing but competitive China market. | Low | SV017, SV014 |
| CV019 | A bear scenario assumes actuator/manufacturing failure, financing freeze, or displacement by the Unitree-AgiBot duopoly. | Medium | SV018, SV020 |
| CV020 | Implied returns span a wide range - large multiples in the bull case to substantial impairment in the bear case. | Low | SV014, SV018 |
| CV021 | Sector bubble warnings imply valuation-multiple compression risk if humanoid hype cools. | Medium | SV020, SV021 |
| CV022 | Analysts caution that Chinese humanoid output is outpacing demonstrated demand, a risk to growth assumptions. | Medium | SV021, SV023 |
| CV023 | The humanoid financing environment remains active but selective, favoring demonstrated commercialization. | Low | SV024, SV010 |
| CV024 | Thesis: rope-driven differentiation plus early orders could yield outsized share in a large future market. | Low | SV022, SV014 |
| CV025 | Anti-thesis: unproven technology, thin disclosure, intense competition, and geopolitical limits could impair value. | Medium | SV018, SV025 |
| CV026 | Thesis-break triggers include systemic actuator failure, a failed production ramp, or a financing freeze. | Medium | SV018, SV020 |
| CV027 | A key kill trigger is persistent negative margins revealed once financials are disclosed. | Medium | SV019, SV026 |
| CV028 | Final diligence asks include audited financials, unit economics, actuator reliability data, and cap-table detail. | Low | SV005, SV018 |
| CV029 | Valuation sensitivity is dominated by assumed unit volume, gross margin, and terminal market share. | Low | SV014, SV016 |
| CV030 | Conditions to upgrade from track to buy: disclosed positive unit economics and proven actuator reliability at scale. | Low | SV022, SV005 |
| CV031 | Key investment KPIs: delivered units, gross margin, order backlog conversion, financing runway, and field-failure rate. | Low | SV027, SV018 |
| CV032 | The Western-peer valuations (Figure, Apptronik, 1X) sit far above Stardust, reflecting different capital markets and hype. | Low | SV009, SV010 |
| CV033 | The analyst TAM range (from tens of billions to ~$38B+ by 2035) bounds plausible long-run enterprise value. | Low | SV014, SV015 |
| CV034 | China's output dominance and policy support underpin a credible domestic base-case growth path. | Low | SV028, SV017 |
| CV035 | Valuation and comparable data are current to mid-2026, reflecting the latest funding rounds and peer marks. | Medium | SV001, SV007 |
| CV036 | The recommendation logic path runs from traction and differentiation, through risk and disclosure gaps, to a track verdict. | Low | SV018, SV022 |
| CV037 | Listed-peer UBTech's public market cap offers a sobering read on how public markets price humanoid makers versus private rounds. | Low | SV012, SV029 |
| CV038 | AgiBot and other Chinese entrants intensify competition for the same capital and customers, pressuring relative valuation. | Low | SV030, SV031 |
| CV039 | Fourier and other domestic humanoid firms broaden the comparable set and the competition for market share. | Low | SV032, SV033 |
| CV040 | Trillion-dollar long-run humanoid market narratives exist but remain speculative and distant, not a near-term anchor. | Medium | SV034, SV014 |